CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands |
9 Months Ended |
12 Months Ended |
|
|
|
|
Sep. 30, 2022
USD ($)
shares
|
Dec. 31, 2021
USD ($)
shares
|
Sep. 30, 2022
GBP (£)
shares
|
Dec. 31, 2021
GBP (£)
shares
|
Sep. 30, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,869,469,000
|
|
$ 2,390,984,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,825,738,000
|
|
2,434,522,000
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
150,539,000
|
[1] |
142,219,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
134,134,000
|
|
184,710,000
|
|
|
|
|
|
|
|
|
Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
31,148,000
|
[1] |
27,147,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
27,159,000
|
|
38,399,000
|
|
|
|
|
|
|
|
|
Investments in Securities [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
2,388,952,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
2,432,708,000
|
|
|
|
|
|
|
|
|
Investment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
2,390,984,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
2,434,522,000
|
|
|
|
|
|
|
|
|
Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
3,139,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
3,046,000
|
|
|
|
|
|
|
|
|
|
|
Senior Secured |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,607,006,000
|
|
$ 2,156,709,000
|
|
|
|
|
|
|
|
|
Senior Secured | Blue Sprig Pediatrics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
|
|
|
4.45%
|
|
|
|
4.45%
|
|
|
|
|
Total Investments Before Cash And Cash Equivalent [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[3] |
2,869,469,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,825,738,000
|
|
|
|
|
|
|
|
|
|
|
Total Investments with Cash and Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[3] |
2,894,469,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[3] |
2,850,738,000
|
|
|
|
|
|
|
|
|
|
|
Total investments In Securities |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
2,866,330,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,822,692,000
|
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents | G S Financial Square Government Fund |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
25,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
25,000,000
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[3] |
25,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[3] |
25,000,000
|
|
|
|
|
|
|
|
|
|
|
Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,684,643,000
|
[1] |
$ 2,219,586,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,661,399,000
|
|
2,209,599,000
|
|
|
|
|
|
|
|
|
Unsecured |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
54,393,000
|
|
52,890,000
|
|
|
|
|
|
|
|
|
Communications & Networking |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
101,094,000
|
|
105,490,000
|
|
|
|
|
|
|
|
|
Communications & Networking | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
1,230,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
6,260,000
|
|
|
|
|
|
|
|
|
Communications & Networking | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
541,000
|
[1] |
418,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
140,000
|
|
0
|
|
|
|
|
|
|
|
|
Communications & Networking | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
98,596,000
|
[1] |
97,088,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
100,954,000
|
|
99,230,000
|
|
|
|
|
|
|
|
|
Communications & Networking | Aryaka Networks, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
123,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 140,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 28, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
229,611
|
|
|
|
229,611
|
|
|
|
|
|
|
Communications & Networking | Peerless Network Holdings, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
1,230,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 6,260,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
1,138,328
|
|
|
|
1,138,328
|
|
|
|
|
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 1,230,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 6,242,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 11, 2008
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
1,135,000
|
|
|
|
1,135,000
|
|
|
|
|
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 18,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Oct. 21, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
3,328
|
|
|
|
3,328
|
|
|
|
|
Communications & Networking | Spring Mobile Solutions, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 418,000
|
[1] |
$ 418,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 19, 2013
|
[5] |
Apr. 19, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
2,834,375
|
|
2,834,375
|
|
2,834,375
|
|
2,834,375
|
|
|
|
|
Communications & Networking | Senior Secured | Aryaka Networks, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-07
|
|
|
|
2026-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.25%
|
|
|
|
3.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
6.75%
|
|
|
|
6.75%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.05%
|
|
|
|
1.05%
|
|
|
|
|
|
|
Principal Amount |
[8],[9],[10] |
$ 5,009,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8],[9],[10] |
4,943,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[10] |
$ 4,943,000
|
|
|
|
|
|
|
|
|
|
|
Communications & Networking | Senior Secured | Cytracom Holdings LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.31%
|
[7] |
9.31%
|
[11] |
9.31%
|
[7] |
9.31%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.31%
|
[7] |
10.31%
|
[11] |
10.31%
|
[7] |
10.31%
|
[11] |
|
|
|
Principal Amount |
|
$ 8,933,000
|
[10],[12],[13] |
$ 9,000,000
|
[14],[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
8,776,000
|
[1],[10],[12],[13] |
8,802,000
|
[4],[14],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,728,000
|
[10],[12],[13] |
$ 8,725,000
|
[14],[15],[16] |
|
|
|
|
|
|
|
Communications & Networking | Senior Secured | Rocket Lab Global Services, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-06
|
|
2024-06
|
|
2024-06
|
|
2024-06
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.25%
|
|
|
|
3.25%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.90%
|
[7] |
4.90%
|
[11] |
4.90%
|
[7] |
4.90%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.15%
|
[7] |
8.15%
|
[11] |
8.15%
|
[7] |
8.15%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.25%
|
[7] |
1.25%
|
[11] |
1.25%
|
[7] |
1.25%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.25%
|
|
|
|
3.25%
|
|
|
|
|
Principal Amount |
|
$ 84,314,000
|
[9],[12],[17],[18],[19] |
$ 88,542,000
|
[20],[21] |
|
|
|
|
|
|
|
Investment cost |
|
84,877,000
|
[1],[9],[12],[17],[18],[19] |
88,286,000
|
[4],[20],[21] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 87,283,000
|
[9],[12],[17],[18],[19] |
90,505,000
|
[20],[21] |
|
|
|
|
|
|
|
Communications & Networking | Senior Secured | Exit Fee | Aryaka Networks, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.55%
|
|
|
|
3.55%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.55%
|
|
|
|
3.55%
|
|
|
|
|
|
|
Communications & Networking | Senior Secured | Exit Fee | Rocket Lab Global Services, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.20%
|
|
|
|
3.20%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.20%
|
|
|
|
3.20%
|
|
|
|
|
|
|
Communications & Networking | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 98,596,000
|
[1] |
97,088,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
100,954,000
|
|
99,230,000
|
|
|
|
|
|
|
|
|
Consumer & Business Products |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
25,497,000
|
|
28,099,000
|
|
|
|
|
|
|
|
|
Consumer & Business Products | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
561,000
|
[1] |
128,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
185,000
|
|
447,000
|
|
|
|
|
|
|
|
|
Consumer & Business Products | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,712,000
|
[1] |
2,145,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,122,000
|
|
4,354,000
|
|
|
|
|
|
|
|
|
Consumer & Business Products | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
[4] |
|
|
23,162,000
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
23,774,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
24,190,000
|
|
23,298,000
|
|
|
|
|
|
|
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[22] |
433,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[22] |
$ 127,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[22] |
61,300
|
|
|
|
61,300
|
|
|
|
|
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
433,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 326,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 30, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
83,625
|
|
|
|
83,625
|
|
|
|
|
Consumer & Business Products | Penumbra Brands, LLC (p.k.a. Gadget Guard) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 228,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jun. 03, 2014
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
1,662,441
|
|
|
|
1,662,441
|
|
|
|
|
Consumer & Business Products | TechStyle, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 128,000
|
[1] |
$ 128,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 58,000
|
|
$ 447,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 30, 2010
|
[5] |
Apr. 30, 2010
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
|
|
|
Consumer & Business Products | TechStyle, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 1,101,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 365,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jul. 16, 2013
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
|
|
206,185
|
|
|
|
|
|
|
Consumer & Business Products | Gadget Guard, LLC | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 228,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 03, 2014
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
1,662,441
|
|
|
|
1,662,441
|
|
|
|
|
|
|
Consumer & Business Products | The Neat Company | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 365,000
|
[1] |
$ 365,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 13, 2014
|
[5] |
Aug. 13, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
54,054
|
|
54,054
|
|
54,054
|
|
54,054
|
|
|
|
|
Consumer & Business Products | Whoop, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 18,000
|
[1] |
$ 18,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 757,000
|
|
$ 1,847,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 27, 2018
|
[5] |
Jun. 27, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
686,270
|
|
686,270
|
|
686,270
|
|
686,270
|
|
|
|
|
Consumer & Business Products | TechStyle, Inc. (p.k.a. Just Fabulous, Inc.) | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 1,101,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 2,181,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jul. 16, 2013
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
206,185
|
|
|
|
206,185
|
|
|
|
|
Consumer & Business Products | Senior Secured | Grove Collaborative, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
6.75%
|
|
|
|
6.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.50%
|
[7] |
5.50%
|
[11] |
5.50%
|
[7] |
5.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.75%
|
[7] |
8.75%
|
[11] |
8.75%
|
[7] |
8.75%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
6.75%
|
|
|
|
6.75%
|
|
|
|
|
Principal Amount |
|
$ 23,520,000
|
[8] |
$ 23,520,000
|
[23] |
|
|
|
|
|
|
|
Investment cost |
|
23,774,000
|
[1],[8] |
23,162,000
|
[4],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 24,190,000
|
[8] |
23,298,000
|
[23] |
|
|
|
|
|
|
|
Consumer & Business Products | Senior Secured | Exit Fee | Grove Collaborative, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Consumer & Business Products | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
[4] |
|
|
23,162,000
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 23,774,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
24,190,000
|
|
23,298,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
72,061,000
|
|
65,073,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
28,444,000
|
[1] |
28,041,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
38,022,000
|
|
32,608,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[4] |
|
|
403,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
403,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
36,545,000
|
[1] |
33,335,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
34,039,000
|
|
32,062,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
28,006,000
|
[1] |
28,006,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 15,623,000
|
|
$ 20,618,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
11,432,752
|
|
11,432,752
|
|
11,432,752
|
|
11,432,752
|
|
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 26,122,000
|
[1],[24] |
$ 26,122,000
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 14,489,000
|
[24] |
$ 19,393,000
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 01, 2018
|
[5] |
Mar. 01, 2018
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
10,602,752
|
[24] |
10,602,752
|
[25] |
10,602,752
|
[24] |
10,602,752
|
[25] |
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,884,000
|
[1],[24] |
$ 1,884,000
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,134,000
|
[24] |
$ 1,225,000
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 01, 2018
|
[5] |
Mar. 01, 2018
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
830,000
|
[24] |
830,000
|
[25] |
830,000
|
[24] |
830,000
|
[25] |
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 25,000,000
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
24,545,000
|
[1] |
24,485,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
22,039,000
|
|
23,212,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Hercules Adviser LLC | Equity | Member Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
35,000
|
[1],[24] |
35,000
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,945,000
|
[24] |
$ 11,990,000
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 26, 2021
|
[5] |
Mar. 26, 2021
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
1
|
[24] |
1
|
[25] |
1
|
[24] |
1
|
[25] |
|
|
|
Diversified Financial Services | Newfront Insurance Holdings, Inc. | Equity | Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 403,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 454,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
210,282
|
|
|
|
210,282
|
|
|
|
|
|
|
Diversified Financial Services | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 36,545,000
|
[1] |
$ 33,738,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 34,039,000
|
|
$ 32,465,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Unsecured | Gibraltar Business Capital, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2026-09
|
|
|
|
2026-09
|
|
|
|
|
Principal Amount |
[25] |
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Unsecured | Hercules Adviser LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
|
|
|
2025-06
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Principal Amount |
[24] |
$ 12,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[24] |
12,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[24] |
$ 12,000,000
|
|
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Unsecured 14.50% | Gibraltar Business Capital, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
|
|
2026-09
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
|
14.50%
|
[7] |
14.50%
|
[11],[25] |
14.50%
|
[7] |
14.50%
|
[11],[25] |
|
|
|
Principal Amount |
[24] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
14,701,000
|
[1],[24] |
$ 14,662,000
|
[4],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 13,033,000
|
[24] |
$ 13,818,000
|
[25] |
|
|
|
|
|
|
|
Diversified Financial Services | Unsecured 11.50% | Gibraltar Business Capital, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
|
11.50%
|
[7] |
11.50%
|
[11],[25] |
11.50%
|
[7] |
11.50%
|
[11],[25] |
|
|
|
Principal Amount |
|
$ 10,000,000
|
[24] |
$ 10,000,000
|
[25] |
|
|
|
|
|
|
|
Investment cost |
|
9,844,000
|
[1],[24] |
9,823,000
|
[4],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
9,006,000
|
[24] |
$ 9,394,000
|
[25] |
|
|
|
|
|
|
|
Diversified Financial Services | Unsecured 5.00 % | Hercules Adviser LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-05
|
|
|
|
2023-05
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
[11],[25] |
|
|
5.00%
|
|
|
|
5.00%
|
|
|
|
|
Principal Amount |
[25] |
|
|
$ 8,850,000
|
|
|
|
|
|
|
|
|
Investment cost |
[4],[25] |
|
|
8,850,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[25] |
|
|
$ 8,850,000
|
|
|
|
|
|
|
|
|
Diversified Financial Services | Convertible Debt | Newfront Insurance Holdings, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-08
|
|
|
|
2022-08
|
|
|
|
|
Investment, Interest Rate, Floor |
[11],[26] |
|
|
0.19%
|
|
|
|
0.19%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11],[26] |
|
|
0.19%
|
|
|
|
0.19%
|
|
|
|
|
Principal Amount |
[26] |
|
|
$ 403,000
|
|
|
|
|
|
|
|
|
Investment cost |
[4],[26] |
|
|
403,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[26] |
|
|
403,000
|
|
|
|
|
|
|
|
|
Investment Funds And Vehicles |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
2,032,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
1,814,000
|
|
|
|
|
|
|
|
|
Investment Funds And Vehicles | Forbion Growth Opportunities Fund I C V |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[15],[27],[28] |
|
|
2,032,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[15],[27],[28] |
|
|
$ 1,814,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27],[28] |
|
|
Nov. 16, 2020
|
|
|
|
|
|
|
|
|
Surgical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,536,000
|
|
$ 1,029,000
|
|
|
|
|
|
|
|
|
Surgical Devices | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,941,000
|
[1] |
1,941,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
0
|
|
543,000
|
|
|
|
|
|
|
|
|
Surgical Devices | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
152,000
|
[1] |
206,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,536,000
|
|
486,000
|
|
|
|
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,941,000
|
[1] |
1,941,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 543,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
9,595,178
|
|
9,595,178
|
|
9,595,178
|
|
9,595,178
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 712,000
|
[1] |
$ 712,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 81,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 08, 2013
|
[5] |
Feb. 08, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,991,157
|
|
1,991,157
|
|
1,991,157
|
|
1,991,157
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250,000
|
[1] |
$ 250,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 9,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 18, 2007
|
[5] |
Jan. 18, 2007
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
219,298
|
|
219,298
|
|
219,298
|
|
219,298
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 282,000
|
[1] |
$ 282,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 26,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 16, 2010
|
[5] |
Jun. 16, 2010
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
656,538
|
|
656,538
|
|
656,538
|
|
656,538
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 429,000
|
[1] |
$ 429,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 131,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 14, 2015
|
[5] |
Jul. 14, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
2,786,367
|
|
2,786,367
|
|
2,786,367
|
|
2,786,367
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 118,000
|
[1] |
$ 118,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 123,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 18, 2018
|
[5] |
Dec. 18, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,523,693
|
|
1,523,693
|
|
1,523,693
|
|
1,523,693
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Series F One Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 150,000
|
[1] |
$ 150,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 173,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 18, 2018
|
[5] |
Dec. 18, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
2,418,125
|
|
2,418,125
|
|
2,418,125
|
|
2,418,125
|
|
|
|
|
Surgical Devices | Gynesonics, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 13,000
|
[1] |
$ 67,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 6,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 05, 2012
|
[5] |
Feb. 08, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
33,670
|
|
151,123
|
|
33,670
|
|
151,123
|
|
|
|
|
Surgical Devices | TransMedics Group, Inc. (p.k.a Transmedics, Inc.) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 139,000
|
[1],[5] |
$ 139,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,536,000
|
[5] |
$ 480,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 07, 2012
|
[5] |
Nov. 07, 2012
|
|
|
|
|
|
|
|
|
Shares | shares |
|
64,440
|
[5] |
64,440
|
[6] |
64,440
|
[5] |
64,440
|
[6] |
|
|
|
Drug Discovery & Development |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,091,827,000
|
|
$ 967,383,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
42,548,000
|
[1] |
33,401,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
32,844,000
|
|
24,860,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
7,709,000
|
[1] |
7,393,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
4,074,000
|
|
4,745,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
2,758,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,665,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
16,378,000
|
[1] |
20,036,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
16,093,000
|
|
20,036,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,039,957,000
|
[1] |
916,421,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,036,151,000
|
|
915,928,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Chemocentryx, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,000,000
|
[1],[5],[29] |
1,000,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 891,000
|
[5],[29] |
$ 628,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 15, 2020
|
[5] |
Jun. 15, 2020
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
17,241
|
[5],[29] |
17,241
|
[6],[27] |
17,241
|
[5],[29] |
17,241
|
[6],[27] |
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[29] |
$ 1,310,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 19, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[29] |
38,461
|
|
|
|
38,461
|
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[29] |
$ 56,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[29] |
$ 398,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 15, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[29] |
18,360
|
|
|
|
18,360
|
|
|
|
|
|
|
Drug Discovery & Development | Albireo Pharma, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1],[5],[29] |
$ 1,000,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 484,000
|
[5],[29] |
$ 582,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 14, 2020
|
[5] |
Sep. 14, 2020
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
25,000
|
[5],[29] |
25,000
|
[6],[27] |
25,000
|
[5],[29] |
25,000
|
[6],[27] |
|
|
|
Drug Discovery & Development | Albireo Pharma, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61,000
|
[1],[5],[29] |
$ 61,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 26,000
|
[5],[29] |
$ 42,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 08, 2020
|
[5] |
Jun. 08, 2020
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
5,311
|
[5],[29] |
5,311
|
[6],[27] |
5,311
|
[5],[29] |
5,311
|
[6],[27] |
|
|
|
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,715,000
|
[1],[5] |
$ 1,715,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,565,000
|
[5] |
$ 892,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 31, 2011
|
[5] |
Jul. 31, 2011
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
190,179
|
[5] |
190,179
|
[6] |
190,179
|
[5] |
190,179
|
[6] |
|
|
|
Drug Discovery & Development | Axsome Therapeutics, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[19],[22],[29] |
$ 4,165,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[19],[22],[29] |
$ 5,360,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 09, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[19],[22],[29] |
127,021
|
|
|
|
127,021
|
|
|
|
|
|
|
Drug Discovery & Development | Axsome Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 880,000
|
[1],[5],[19],[29] |
$ 681,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 783,000
|
[5],[19],[29] |
$ 142,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 25, 2020
|
[5] |
Sep. 25, 2020
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
40,396
|
[5],[19],[22],[29] |
15,541
|
[6],[27] |
40,396
|
[5],[19],[22],[29] |
15,541
|
[6],[27] |
|
|
|
Drug Discovery & Development | Bicycle Therapeutics PLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,871,000
|
[1],[5],[29],[30] |
$ 1,871,000
|
[2],[6],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,282,000
|
[5],[29],[30] |
$ 5,971,000
|
[6],[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 05, 2020
|
[5] |
Oct. 05, 2020
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
98,100
|
[5],[29],[30] |
98,100
|
[6],[27],[28] |
98,100
|
[5],[29],[30] |
98,100
|
[6],[27],[28] |
|
|
|
Drug Discovery & Development | BridgeBio Pharma, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,255,000
|
[1],[5] |
$ 2,255,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,299,000
|
[5] |
$ 3,859,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 21, 2018
|
[5] |
Jun. 21, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
231,329
|
[5] |
231,329
|
[6] |
231,329
|
[5] |
231,329
|
[6] |
|
|
|
Drug Discovery & Development | Cellarity, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 287,000
|
[1],[31] |
$ 287,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 370,000
|
[31] |
$ 287,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 08, 2021
|
[5] |
Dec. 08, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
100,000
|
[31] |
100,000
|
[32] |
100,000
|
[31] |
100,000
|
[32] |
|
|
|
Drug Discovery & Development | Century Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 37,000
|
[1],[5] |
$ 37,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 16,000
|
[5] |
$ 64,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 14, 2020
|
[5] |
Sep. 14, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
16,112
|
[5] |
16,112
|
[6] |
16,112
|
[5] |
16,112
|
[6] |
|
|
|
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
$ 72,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 31,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Dec. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[29],[30] |
133,692
|
|
|
|
133,692
|
|
|
|
|
|
|
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3 Class C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
|
|
$ 64,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[27],[28] |
|
|
$ 64,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27],[28] |
|
|
Dec. 30, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
[27],[28] |
|
|
84,714
|
|
|
|
84,714
|
|
|
|
|
Drug Discovery & Development | Hibercell, Inc. | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,250,000
|
[1],[31] |
$ 4,250,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,917,000
|
[31] |
$ 3,264,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 07, 2021
|
[5] |
May 07, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
3,466,840
|
[31] |
3,466,840
|
[32] |
3,466,840
|
[31] |
3,466,840
|
[32] |
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 4,021,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 03, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
235,295
|
|
|
|
235,295
|
|
|
|
|
|
|
Drug Discovery & Development | Humanigen, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 800,000
|
[1],[5],[29] |
$ 800,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,000
|
[5],[29] |
$ 161,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 31, 2021
|
[5] |
Mar. 31, 2021
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
43,243
|
[5],[29] |
43,243
|
[6],[27] |
43,243
|
[5],[29] |
43,243
|
[6],[27] |
|
|
|
Drug Discovery & Development | Kaleido Biosciences, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 207,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Feb. 10, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
86,585
|
|
|
|
86,585
|
|
|
|
|
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[29] |
$ 177,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[29] |
$ 214,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 09, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[29] |
10,131
|
|
|
|
10,131
|
|
|
|
|
|
|
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 848,000
|
[1],[5],[19],[29],[31] |
$ 848,000
|
[2],[6],[27],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 113,000
|
[5],[19],[29],[31] |
$ 307,000
|
[6],[21],[27],[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 17, 2021
|
[5] |
Sep. 17, 2021
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
64,687
|
[5],[19],[29],[31] |
64,687
|
[6],[21],[27],[32] |
64,687
|
[5],[19],[29],[31] |
64,687
|
[6],[21],[27],[32] |
|
|
|
Drug Discovery & Development | Provention Bio, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
$ 281,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 224,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 15, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
111,934
|
|
|
|
111,934
|
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[31] |
$ 18,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[31] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[31] |
475,510
|
|
|
|
475,510
|
|
|
|
|
|
|
Drug Discovery & Development | Scynexis, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 296,000
|
[1],[5] |
$ 188,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 47,000
|
[5] |
$ 142,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 14, 2021
|
[5] |
May 14, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
106,035
|
[5] |
90,887
|
[6] |
106,035
|
[5] |
90,887
|
[6] |
|
|
|
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[29] |
$ 2,100,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[29] |
$ 2,663,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 05, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[29] |
155,555
|
|
|
|
155,555
|
|
|
|
|
|
|
Drug Discovery & Development | TG Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,033,000
|
[1],[5],[18],[29] |
$ 1,033,000
|
[2],[6],[27],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 335,000
|
[5],[18],[29] |
$ 2,172,000
|
[6],[27],[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 28, 2019
|
[5] |
Feb. 28, 2019
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
231,613
|
[5],[18],[29] |
231,613
|
[6],[27],[33] |
231,613
|
[5],[18],[29] |
231,613
|
[6],[27],[33] |
|
|
|
Drug Discovery & Development | Uni Qure B V | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 332,000
|
[1],[5],[19],[29],[30] |
$ 332,000
|
[2],[6],[21],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 322,000
|
[5],[19],[29],[30] |
$ 356,000
|
[6],[21],[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 31, 2019
|
[5] |
Jan. 31, 2019
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
17,175
|
[5],[19],[29],[30] |
17,175
|
[6],[21],[27],[28] |
17,175
|
[5],[19],[29],[30] |
17,175
|
[6],[21],[27],[28] |
|
|
|
Drug Discovery & Development | Valo Health L L C | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,000,000
|
[1] |
$ 3,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 3,622,000
|
|
$ 4,650,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 11, 2020
|
[5] |
Dec. 11, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
510,308
|
|
510,308
|
|
510,308
|
|
510,308
|
|
|
|
|
Drug Discovery & Development | Valo Health L L C | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 242,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 15, 2020
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Valo Health L L C | Warrant Investment | Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 256,000
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
102,216
|
|
|
|
102,216
|
|
|
|
|
|
|
Drug Discovery & Development | X Four Pharmaceuticals Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,522,000
|
[1],[5] |
$ 1,641,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,901,000
|
[5] |
$ 454,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 26, 2019
|
[5] |
Nov. 26, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,111,519
|
[5] |
198,277
|
[6] |
1,111,519
|
[5] |
198,277
|
[6] |
|
|
|
Drug Discovery & Development | X Four Pharmaceuticals Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 792,000
|
[1],[5] |
$ 673,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 628,000
|
[5] |
$ 2,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 18, 2019
|
[5] |
Mar. 18, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,021,576
|
[5] |
108,334
|
[6] |
1,021,576
|
[5] |
108,334
|
[6] |
|
|
|
Drug Discovery & Development | Applied Molecular Transport | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 42,000
|
[1],[5],[29] |
$ 42,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,000
|
[5],[29] |
$ 14,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 06, 2021
|
[5] |
Apr. 06, 2021
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
1,000
|
[5],[29] |
1,000
|
[6],[27] |
1,000
|
[5],[29] |
1,000
|
[6],[27] |
|
|
|
Drug Discovery & Development | Avalo Therapeutics, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1],[5] |
$ 1,000,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 33,000
|
[5] |
$ 202,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 19, 2014
|
[5] |
Aug. 19, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
9,924
|
[5] |
119,087
|
[6] |
9,924
|
[5] |
119,087
|
[6] |
|
|
|
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,367,000
|
[1],[5],[29] |
$ 1,367,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 474,000
|
[5],[29] |
$ 223,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 13, 2019
|
[5] |
Feb. 13, 2019
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
70,796
|
[5],[29] |
70,796
|
[6],[27] |
70,796
|
[5],[29] |
70,796
|
[6],[27] |
|
|
|
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6],[27] |
|
|
$ 178,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6],[27] |
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27] |
|
|
Jun. 08, 2017
|
|
|
|
|
|
|
|
|
Shares | shares |
[6],[27] |
|
|
61,273
|
|
|
|
61,273
|
|
|
|
|
Drug Discovery & Development | Dare Biosciences, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1],[5] |
$ 1,000,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 14,000
|
[5] |
$ 27,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 08, 2015
|
[5] |
Jan. 08, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
13,550
|
[5] |
13,550
|
[6] |
13,550
|
[5] |
13,550
|
[6] |
|
|
|
Drug Discovery & Development | Dynavax Technologies | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550,000
|
[1],[5],[29] |
$ 550,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 209,000
|
[5],[29] |
$ 281,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 22, 2015
|
[5] |
Jul. 22, 2015
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
20,000
|
[5],[29] |
20,000
|
[6],[27] |
20,000
|
[5],[29] |
20,000
|
[6],[27] |
|
|
|
Drug Discovery & Development | NorthSea Therapeutics | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000,000
|
[1],[29],[30] |
$ 2,000,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,515,000
|
[29],[30] |
$ 2,000,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 15, 2021
|
[5] |
Dec. 15, 2021
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
983
|
[29],[30] |
983
|
[27],[28] |
983
|
[29],[30] |
983
|
[27],[28] |
|
|
|
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,744,000
|
[1],[5] |
$ 2,744,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 196,000
|
[5] |
$ 343,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 26, 2007
|
[5] |
Feb. 26, 2007
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
76,362
|
[5] |
76,362
|
[6] |
76,362
|
[5] |
76,362
|
[6] |
|
|
|
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 520,000
|
[1],[5] |
$ 546,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 72,000
|
[5] |
$ 427,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 01, 2018
|
[5] |
Jun. 27, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
426,866
|
[5] |
432,240
|
[6] |
426,866
|
[5] |
432,240
|
[6] |
|
|
|
Drug Discovery & Development | Rocket Pharmaceuticals, Ltd. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500,000
|
[1],[5] |
$ 1,500,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 15,000
|
[5] |
$ 21,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 22, 2007
|
[5] |
Aug. 22, 2007
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
944
|
[5] |
944
|
[6] |
944
|
[5] |
944
|
[6] |
|
|
|
Drug Discovery & Development | Savara, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 203,000
|
[1],[5] |
$ 202,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 17,000
|
[5] |
$ 14,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 11, 2015
|
[5] |
Aug. 11, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
11,119
|
[5] |
11,119
|
[6] |
11,119
|
[5] |
11,119
|
[6] |
|
|
|
Drug Discovery & Development | Sio Gene Therapies, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,269,000
|
[1],[5] |
$ 1,269,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 4,000
|
[5] |
$ 21,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 02, 2017
|
[5] |
Feb. 02, 2017
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
16,228
|
[5] |
16,228
|
[6],[27] |
16,228
|
[5] |
16,228
|
[6],[27] |
|
|
|
Drug Discovery & Development | Tricida, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 863,000
|
[1],[5] |
$ 863,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 721,000
|
[5] |
$ 658,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 28, 2018
|
[5] |
Feb. 28, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
68,816
|
[5] |
68,816
|
[6] |
68,816
|
[5] |
68,816
|
[6] |
|
|
|
Drug Discovery & Development | Tricida, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 280,000
|
[1],[5] |
$ 280,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 22,000
|
[5] |
$ 20,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 27, 2019
|
[5] |
Mar. 27, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
31,352
|
[5] |
31,352
|
[6] |
31,352
|
[5] |
31,352
|
[6] |
|
|
|
Drug Discovery & Development | ADMA Biologics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 295,000
|
[1],[5] |
$ 295,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,000
|
[5] |
$ 1,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 21, 2012
|
[5] |
Dec. 21, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
89,750
|
[5] |
89,750
|
[6] |
89,750
|
[5] |
89,750
|
[6] |
|
|
|
Drug Discovery & Development | Brickell Biotech, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 119,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Feb. 18, 2016
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
9,005
|
|
|
|
9,005
|
|
|
|
|
Drug Discovery & Development | Dermavant Sciences Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 101,000
|
[1],[18],[29],[30] |
$ 101,000
|
[2],[27],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 104,000
|
[18],[29],[30] |
$ 354,000
|
[27],[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 31, 2019
|
[5] |
May 31, 2019
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
223,642
|
[18],[29],[30] |
223,642
|
[27],[33] |
223,642
|
[18],[29],[30] |
223,642
|
[27],[33] |
|
|
|
Drug Discovery & Development | Evofem Biosciences, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 266,000
|
[1],[5] |
$ 266,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[5] |
$ 0
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 11, 2014
|
[5] |
Jun. 11, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
520
|
[5] |
7,806
|
[6] |
520
|
[5] |
7,806
|
[6] |
|
|
|
Drug Discovery & Development | Myovant Sciences, Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 460,000
|
[1],[5],[29],[30] |
$ 460,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 429,000
|
[5],[29],[30] |
$ 267,000
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 16, 2017
|
[5] |
Oct. 16, 2017
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
73,710
|
[5],[29],[30] |
73,710
|
[6],[27] |
73,710
|
[5],[29],[30] |
73,710
|
[6],[27] |
|
|
|
Drug Discovery & Development | Stealth Bio Therapeutics Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 158,000
|
[1],[5],[29],[30] |
$ 158,000
|
[2],[6],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[5],[29],[30] |
$ 0
|
[6],[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 30, 2017
|
[5] |
Jun. 30, 2017
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
500,000
|
[5],[29],[30] |
500,000
|
[6],[27] |
500,000
|
[5],[29],[30] |
500,000
|
[6],[27] |
|
|
|
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 110,000
|
[1],[5] |
$ 110,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[5] |
$ 3,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 20, 2019
|
[5] |
Dec. 20, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
15,414
|
[5] |
15,414
|
[6] |
15,414
|
[5] |
15,414
|
[6] |
|
|
|
Drug Discovery & Development | Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
$ 119,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Feb. 18, 2016
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
200
|
|
|
|
200
|
|
|
|
|
|
|
Drug Discovery & Development | Forbion Growth Opportunities Fund I C V | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29],[30] |
$ 2,353,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29],[30] |
$ 2,291,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Nov. 16, 2020
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Forbion Growth Opportunities Fund I I C V | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29],[30] |
$ 405,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29],[30] |
$ 374,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Valo Health, LLC (p.k.a. Integral Health Holdings, LLC) | Warrant Investment | Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 256,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 441,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jun. 15, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
102,216
|
|
|
|
102,216
|
|
|
|
|
Drug Discovery & Development | Acacia Pharma Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 304,000
|
[1],[29],[30] |
$ 305,000
|
[2],[6],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[29],[30] |
$ 6,000
|
[6],[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 29, 2018
|
[5] |
Jun. 29, 2018
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
201,330
|
[29],[30] |
201,330
|
[6],[27],[28] |
201,330
|
[29],[30] |
201,330
|
[6],[27],[28] |
|
|
|
Drug Discovery & Development | Genocea Biosciences Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 32,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Nov. 20, 2014
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
27,933
|
|
|
|
27,933
|
|
|
|
|
Drug Discovery & Development | Genocea Biosciences Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 165,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 24, 2018
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
41,176
|
|
|
|
41,176
|
|
|
|
|
Drug Discovery & Development | Motif Bio P L C | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
|
|
$ 282,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[27] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27] |
|
|
Jan. 27, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
[27] |
|
|
121,337,041
|
|
|
|
121,337,041
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Chemocentryx, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2022-12
|
|
2022-12
|
|
2022-12
|
|
2022-12
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.30%
|
[7] |
3.30%
|
[11],[27] |
3.30%
|
[7] |
3.30%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
8.05%
|
[7] |
8.05%
|
[11],[27] |
8.05%
|
[7] |
8.05%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Principal Amount |
|
$ 11,451,000
|
[17],[29] |
$ 18,951,000
|
[27] |
|
|
|
|
|
|
|
Investment cost |
|
12,677,000
|
[1],[17],[29] |
20,036,000
|
[4],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 12,780,000
|
[17],[29] |
$ 20,036,000
|
[27] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Chemocentryx, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
7.15%
|
|
|
|
7.15%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.25%
|
[7] |
3.25%
|
[11],[27] |
3.25%
|
[7] |
3.25%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
8.50%
|
[7] |
8.50%
|
[11],[27] |
8.50%
|
[7] |
8.50%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
7.15%
|
|
|
|
7.15%
|
|
|
|
|
Principal Amount |
|
$ 5,000,000
|
[17],[29] |
$ 5,000,000
|
[27] |
|
|
|
|
|
|
|
Investment cost |
|
5,214,000
|
[1],[17],[29] |
5,161,000
|
[2],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 5,408,000
|
[17],[29] |
$ 5,070,000
|
[27] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Nabriva Therapeutics | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-06
|
|
|
|
2023-06
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.30%
|
|
|
|
4.30%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.80%
|
|
|
|
9.80%
|
|
|
|
|
|
|
Principal Amount |
[17],[29],[30] |
$ 3,077,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[17],[29],[30] |
3,701,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[17],[29],[30] |
$ 3,313,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Nabriva Therapeutics | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-06
|
|
|
|
2023-06
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11],[27],[28] |
|
|
4.30%
|
|
|
|
4.30%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11],[27],[28] |
|
|
9.80%
|
|
|
|
9.80%
|
|
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Principal Amount |
[27],[28] |
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
|
|
5,500,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[27],[28] |
|
|
$ 5,459,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Akero Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
|
|
2027-01
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.65%
|
|
|
|
3.65%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.65%
|
|
|
|
7.65%
|
|
|
|
|
|
|
Principal Amount |
[10],[29] |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29] |
4,966,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29] |
$ 4,983,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Albireo Pharma, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-07
|
|
|
|
2024-07
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11],[27] |
|
|
5.90%
|
|
|
|
5.90%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11],[27] |
|
|
9.15%
|
|
|
|
9.15%
|
|
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Principal Amount |
[14],[27] |
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[4],[14],[27] |
|
|
10,229,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14],[27] |
|
|
$ 10,268,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Alladapt Immunotherapeutics Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
|
|
2026-09
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.65%
|
|
|
|
3.65%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.40%
|
|
|
|
8.40%
|
|
|
|
|
|
|
Principal Amount |
[10] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10] |
14,858,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10] |
$ 14,858,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Aldeyra Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-10
|
|
2023-10
|
|
2023-10
|
|
2023-10
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.10%
|
[7] |
3.10%
|
[11] |
3.10%
|
[7] |
3.10%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.60%
|
[7] |
8.60%
|
[11] |
8.60%
|
[7] |
8.60%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Principal Amount |
|
$ 15,000,000
|
[12] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
15,817,000
|
[1],[12] |
15,639,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 15,608,000
|
[12] |
$ 15,653,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Applied Genetic Technologies Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
9.75%
|
|
|
|
9.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.50%
|
[7] |
6.50%
|
[11] |
6.50%
|
[7] |
6.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.75%
|
|
|
|
9.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
9.75%
|
|
|
|
9.75%
|
|
|
|
|
Principal Amount |
|
$ 15,609,000
|
[17] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
16,450,000
|
[1],[17] |
20,416,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 16,308,000
|
[17] |
$ 20,339,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | ATAI Life Sciences N.V. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
|
|
|
2026-08
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.55%
|
|
|
|
4.55%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.55%
|
|
|
|
8.55%
|
|
|
|
|
|
|
Principal Amount |
[10],[29],[30] |
$ 10,500,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29],[30] |
10,467,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29],[30] |
$ 10,467,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Aveo Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.40%
|
[7] |
6.40%
|
[11] |
6.40%
|
[7] |
6.40%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.65%
|
[7] |
9.65%
|
[11] |
9.65%
|
[7] |
9.65%
|
[11] |
|
|
|
Principal Amount |
|
$ 40,000,000
|
[12],[31] |
$ 40,000,000
|
[14],[32] |
|
|
|
|
|
|
|
Investment cost |
|
41,439,000
|
[1],[12],[31] |
40,842,000
|
[4],[14],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 41,374,000
|
[12],[31] |
$ 40,776,000
|
[14],[32] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Axsome Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
5.82%
|
|
|
|
5.82%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[11],[27] |
5.70%
|
[7] |
5.70%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11],[27] |
8.95%
|
[7] |
8.95%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
5.82%
|
|
|
|
5.82%
|
|
|
|
|
Principal Amount |
|
$ 81,725,000
|
[10],[12],[18],[19],[29] |
$ 50,000,000
|
[27],[33] |
|
|
|
|
|
|
|
Investment cost |
|
81,388,000
|
[1],[10],[12],[18],[19],[29] |
49,542,000
|
[4],[27],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 79,295,000
|
[10],[12],[18],[19],[29] |
$ 48,859,000
|
[27],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Bicycle Therapeutics PLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2024-10
|
|
2025-07
|
|
2024-10
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
5.00%
|
|
|
|
5.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.55%
|
[7] |
5.60%
|
[11],[27],[28] |
4.55%
|
[7] |
5.60%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
8.05%
|
[7] |
8.85%
|
[11],[27],[28] |
8.05%
|
[7] |
8.85%
|
[11],[27],[28] |
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
5.00%
|
|
|
|
5.00%
|
|
|
|
|
Principal Amount |
|
$ 11,500,000
|
[12],[18],[29],[30] |
$ 24,000,000
|
[14],[15],[27],[28],[33] |
|
|
|
|
|
|
|
Investment cost |
|
11,724,000
|
[1],[12],[18],[29],[30] |
24,271,000
|
[4],[14],[15],[27],[28],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 11,619,000
|
[12],[18],[29],[30] |
$ 24,454,000
|
[14],[15],[27],[28],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | BiomX, INC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-09
|
|
2025-09
|
|
2025-09
|
|
2025-09
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[11],[27],[28] |
5.70%
|
[7] |
5.70%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11],[27],[28] |
8.95%
|
[7] |
8.95%
|
[11],[27],[28] |
|
|
|
Principal Amount |
|
$ 9,000,000
|
[12],[29],[30] |
$ 9,000,000
|
[14],[27],[28] |
|
|
|
|
|
|
|
Investment cost |
|
9,125,000
|
[1],[12],[29],[30] |
8,980,000
|
[4],[14],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 9,004,000
|
[12],[29],[30] |
$ 8,980,000
|
[14],[27],[28] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | BridgeBio Pharma, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
|
9.00%
|
[7] |
9.00%
|
[11] |
9.00%
|
[7] |
9.00%
|
[11] |
|
|
|
Investment Interest Rate |
[11] |
|
|
2.00%
|
|
|
|
2.00%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
2.00%
|
|
|
|
2.00%
|
|
|
|
|
Principal Amount |
|
$ 37,022,000
|
[9],[17],[18] |
$ 38,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
36,694,000
|
[1],[9],[17],[18] |
37,462,000
|
[4] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 33,561,000
|
[9],[17],[18] |
$ 37,462,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cellarity, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
2026-06
|
|
2026-06
|
|
2026-06
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.75%
|
|
|
|
3.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[11] |
5.70%
|
[7] |
5.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11] |
8.95%
|
[7] |
8.95%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.75%
|
|
|
|
3.75%
|
|
|
|
|
Principal Amount |
|
$ 30,000,000
|
[17],[31] |
$ 30,000,000
|
[32] |
|
|
|
|
|
|
|
Investment cost |
|
29,734,000
|
[1],[17],[31] |
29,422,000
|
[4],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 29,943,000
|
[17],[31] |
$ 29,422,000
|
[32] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Century Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.30%
|
[7] |
6.30%
|
[11] |
6.30%
|
[7] |
6.30%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.55%
|
[7] |
9.55%
|
[11] |
9.55%
|
[7] |
9.55%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Principal Amount |
|
$ 10,000,000
|
[12] |
$ 10,000,000
|
[14] |
|
|
|
|
|
|
|
Investment cost |
|
10,197,000
|
[1],[12] |
10,075,000
|
[4],[14] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 10,261,000
|
[12] |
$ 10,361,000
|
[14] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Codiak Biosciences, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-10
|
|
2025-10
|
|
2025-10
|
|
2025-10
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[11] |
5.00%
|
[7] |
5.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.25%
|
[7] |
8.25%
|
[11] |
8.25%
|
[7] |
8.25%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Principal Amount |
|
$ 25,000,000
|
[12] |
$ 25,000,000
|
[14] |
|
|
|
|
|
|
|
Investment cost |
|
25,681,000
|
[1],[12] |
25,459,000
|
[2],[14] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 25,076,000
|
[12] |
$ 25,316,000
|
[14] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Corium, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
7.75%
|
|
|
|
7.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[11] |
5.70%
|
[7] |
5.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11] |
8.95%
|
[7] |
8.95%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
7.75%
|
|
|
|
7.75%
|
|
|
|
|
Principal Amount |
|
$ 132,675,000
|
[17],[19] |
$ 91,500,000
|
[21] |
|
|
|
|
|
|
|
Investment cost |
|
133,069,000
|
[1],[17],[19] |
90,997,000
|
[2],[21] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 135,828,000
|
[17],[19] |
$ 90,997,000
|
[21] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Eloxx Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
6.25%
|
|
|
|
6.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
|
9.50%
|
[7] |
9.50%
|
[11] |
9.50%
|
[7] |
9.50%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Principal Amount |
|
$ 12,500,000
|
[31] |
$ 12,500,000
|
[32] |
|
|
|
|
|
|
|
Investment cost |
|
12,673,000
|
[1],[31] |
12,443,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 12,408,000
|
[31] |
$ 12,443,000
|
[32] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | enGene, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
6.35%
|
|
|
|
6.35%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[11],[27],[28] |
5.00%
|
[7] |
5.00%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
[11],[27],[28] |
|
|
8.25%
|
|
|
|
8.25%
|
|
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
6.35%
|
|
|
|
6.35%
|
|
|
|
|
Principal Amount |
|
$ 11,000,000
|
[17],[29],[30] |
$ 7,000,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment cost |
|
10,994,000
|
[1],[17],[29],[30] |
6,858,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 10,918,000
|
[17],[29],[30] |
$ 6,858,000
|
[27],[28] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Finch Therapeutics Group, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
|
|
2026-11
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.05%
|
|
|
|
4.05%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.55%
|
|
|
|
7.55%
|
|
|
|
|
|
|
Principal Amount |
[10] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10] |
14,958,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10] |
$ 14,241,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | G1 Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
9.86%
|
|
|
|
9.86%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.90%
|
[7] |
5.90%
|
[11],[27] |
5.90%
|
[7] |
5.90%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
9.15%
|
[7] |
9.15%
|
[11],[27] |
9.15%
|
[7] |
9.15%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
9.86%
|
|
|
|
9.86%
|
|
|
|
|
Principal Amount |
|
$ 58,125,000
|
[10],[12],[18],[31] |
$ 58,125,000
|
[14],[15],[27],[32],[33] |
|
|
|
|
|
|
|
Investment cost |
|
58,472,000
|
[1],[10],[12],[18],[31] |
57,873,000
|
[2],[14],[15],[27],[32],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 58,006,000
|
[10],[12],[18],[31] |
$ 57,874,000
|
[14],[15],[27],[32],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Geron Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
6.55%
|
|
|
|
6.55%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.75%
|
[7] |
5.75%
|
[11],[27] |
5.75%
|
[7] |
5.75%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
9.00%
|
[7] |
9.00%
|
[11],[27] |
9.00%
|
[7] |
9.00%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
6.55%
|
|
|
|
6.55%
|
|
|
|
|
Principal Amount |
|
$ 18,500,000
|
[17],[18],[29] |
$ 32,500,000
|
[27],[33] |
|
|
|
|
|
|
|
Investment cost |
|
19,003,000
|
[1],[17],[18],[29] |
32,704,000
|
[2],[27],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 19,059,000
|
[17],[18],[29] |
$ 32,744,000
|
[27],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Gritstone Bio, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.15%
|
|
|
|
3.15%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.15%
|
|
|
|
7.15%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
2.00%
|
|
|
|
2.00%
|
|
|
|
|
|
|
Principal Amount |
[9],[10] |
$ 15,037,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[10] |
14,989,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[10] |
$ 14,989,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Hibercell, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-05
|
|
2025-05
|
|
2025-05
|
|
2025-05
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.40%
|
[7] |
5.40%
|
[11] |
5.40%
|
[7] |
5.40%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.65%
|
[7] |
8.65%
|
[11] |
8.65%
|
[7] |
8.65%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Principal Amount |
|
$ 17,000,000
|
[17],[31] |
$ 17,000,000
|
[32] |
|
|
|
|
|
|
|
Investment cost |
|
17,244,000
|
[1],[17],[31] |
17,041,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 17,225,000
|
[17],[31] |
$ 17,014,000
|
[32] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | HilleVax, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
|
|
|
2027-05
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
1.05%
|
|
|
|
1.05%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
4.55%
|
|
|
|
4.55%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
2.85%
|
|
|
|
2.85%
|
|
|
|
|
|
|
Principal Amount |
[9],[10],[31] |
$ 4,043,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[10],[31] |
4,043,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[10],[31] |
$ 4,044,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Iveric Bio Gene Therapy LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-08
|
|
|
|
2027-08
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.00%
|
|
|
|
4.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Principal Amount |
[10],[29] |
$ 24,750,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29] |
24,530,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29] |
$ 24,531,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Humanigen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2025-03
|
|
|
|
2025-03
|
|
|
|
|
Investment Interest Rate |
[11],[26],[27] |
|
|
6.75%
|
|
|
|
6.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11],[26],[27] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11],[26],[27] |
|
|
8.75%
|
|
|
|
8.75%
|
|
|
|
|
Interest Rate and Floor |
[11],[26],[27] |
|
|
6.75%
|
|
|
|
6.75%
|
|
|
|
|
Principal Amount |
[26],[27] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26],[27] |
|
|
20,235,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[26],[27] |
|
|
$ 19,985,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Kaleido Biosciences, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-01
|
|
|
|
2024-01
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
7.55%
|
|
|
|
7.55%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
6.10%
|
|
|
|
6.10%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
9.35%
|
|
|
|
9.35%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
7.55%
|
|
|
|
7.55%
|
|
|
|
|
Principal Amount |
[33] |
|
|
$ 22,500,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
|
|
23,505,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[33] |
|
|
$ 23,384,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Locus Biosciences, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.10%
|
[7] |
6.10%
|
[11] |
6.10%
|
[7] |
6.10%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.35%
|
[7] |
9.35%
|
[11] |
9.35%
|
[7] |
9.35%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Principal Amount |
|
$ 8,000,000
|
[31] |
$ 8,000,000
|
[32] |
|
|
|
|
|
|
|
Investment cost |
|
8,084,000
|
[1],[31] |
7,977,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,062,000
|
[31] |
$ 7,900,000
|
[32] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Madrigal Pharmaceutical, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
|
|
2026-05
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.45%
|
|
|
|
7.45%
|
|
|
|
|
|
|
Principal Amount |
[29] |
$ 34,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29] |
33,807,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29] |
$ 33,807,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Phathom Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
7.50%
|
|
|
|
7.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
2.25%
|
[7] |
2.25%
|
[11],[27] |
2.25%
|
[7] |
2.25%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
5.50%
|
[7] |
5.50%
|
[11],[27] |
5.50%
|
[7] |
5.50%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
3.35%
|
[7] |
3.35%
|
[11],[27] |
3.35%
|
[7] |
3.35%
|
[11],[27] |
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
7.50%
|
|
|
|
7.50%
|
|
|
|
|
Principal Amount |
|
$ 93,978,000
|
[9],[10],[18],[19],[29],[31] |
$ 87,116,000
|
[15],[20],[21],[27],[32],[33] |
|
|
|
|
|
|
|
Investment cost |
|
93,948,000
|
[1],[9],[10],[18],[19],[29],[31] |
86,075,000
|
[2],[15],[20],[21],[27],[32],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 94,006,000
|
[9],[10],[18],[19],[29],[31] |
$ 86,075,000
|
[15],[20],[21],[27],[32],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Provention Bio, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
|
|
2026-09
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
2.70%
|
|
|
|
2.70%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.20%
|
|
|
|
8.20%
|
|
|
|
|
|
|
Principal Amount |
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
24,552,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 24,552,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Redshift Bioanalytics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-01
|
|
|
|
2026-01
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.25%
|
|
|
|
4.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.50%
|
|
|
|
7.50%
|
|
|
|
|
|
|
Principal Amount |
[31] |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[31] |
4,936,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[31] |
$ 4,935,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Scynexis, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.80%
|
[7] |
5.80%
|
[11] |
5.80%
|
[7] |
5.80%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.05%
|
[7] |
9.05%
|
[11] |
9.05%
|
[7] |
9.05%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Principal Amount |
|
$ 18,667,000
|
[17],[18] |
$ 16,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
18,592,000
|
[1],[17],[18] |
15,826,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 18,524,000
|
[17],[18] |
$ 15,778,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Seres Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2023-11
|
|
2024-10
|
|
2023-11
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.85%
|
|
|
|
4.85%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.40%
|
[7] |
4.40%
|
[11] |
6.40%
|
[7] |
4.40%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.65%
|
[7] |
9.65%
|
[11] |
9.65%
|
[7] |
9.65%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.85%
|
|
|
|
4.85%
|
|
|
|
|
Principal Amount |
|
$ 37,500,000
|
[17],[18] |
$ 24,051,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
38,509,000
|
[1],[17],[18] |
24,777,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 38,657,000
|
[17],[18] |
$ 25,183,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Syndax Pharmaceutics Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-04
|
|
|
|
2024-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.99%
|
|
|
|
4.99%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
6.00%
|
|
|
|
6.00%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
9.25%
|
|
|
|
9.25%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.99%
|
|
|
|
4.99%
|
|
|
|
|
Principal Amount |
[15],[33] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[15],[33] |
|
|
20,646,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[15],[33] |
|
|
$ 20,653,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Tarsus Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-02
|
|
|
|
2027-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.20%
|
|
|
|
5.20%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.45%
|
|
|
|
8.45%
|
|
|
|
|
|
|
Principal Amount |
[10],[17],[29] |
$ 8,250,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[17],[29] |
8,255,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[29] |
$ 8,388,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | TG Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
|
|
|
Investment Interest Rate |
[11],[27] |
|
|
5.95%
|
|
|
|
5.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
2.15%
|
[7] |
2.15%
|
[11],[27] |
2.15%
|
[7] |
2.15%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Floor |
|
5.40%
|
[7] |
5.40%
|
[11],[27] |
5.40%
|
[7] |
5.40%
|
[11],[27] |
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
3.45%
|
|
|
|
3.45%
|
|
|
|
|
|
|
Interest Rate and Floor |
[11],[27] |
|
|
5.95%
|
|
|
|
5.95%
|
|
|
|
|
Principal Amount |
|
$ 47,567,000
|
[9],[12],[18],[29] |
$ 51,450,000
|
[27] |
|
|
|
|
|
|
|
Investment cost |
|
47,267,000
|
[1],[9],[12],[18],[29] |
50,470,000
|
[2],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 47,137,000
|
[9],[12],[18],[29] |
$ 50,470,000
|
[27] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Uni Qure B V | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
7.28%
|
|
|
|
7.28%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.70%
|
[7] |
4.70%
|
[11],[27],[28] |
4.70%
|
[7] |
4.70%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
7.95%
|
[7] |
7.95%
|
[11],[27],[28] |
7.95%
|
[7] |
7.95%
|
[11],[27],[28] |
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
7.28%
|
|
|
|
7.28%
|
|
|
|
|
Principal Amount |
|
$ 70,000,000
|
[12],[18],[19],[29],[30] |
$ 77,500,000
|
[14],[21],[27],[28],[33] |
|
|
|
|
|
|
|
Investment cost |
|
72,015,000
|
[1],[12],[18],[19],[29],[30] |
78,755,000
|
[2],[14],[21],[27],[28],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 73,205,000
|
[12],[18],[19],[29],[30] |
$ 78,755,000
|
[14],[21],[27],[28],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Unity Biotechnology Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
|
|
|
Investment Interest Rate |
[11],[26] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.10%
|
[7] |
6.10%
|
[11],[26] |
6.10%
|
[7] |
6.10%
|
[11],[26] |
|
|
|
Investment, Interest Rate, Floor |
|
9.35%
|
[7] |
9.35%
|
[11],[26] |
9.35%
|
[7] |
9.35%
|
[11],[26] |
|
|
|
Interest Rate and Floor |
[11],[26] |
|
|
6.25%
|
|
|
|
6.25%
|
|
|
|
|
Principal Amount |
|
$ 20,000,000
|
[17] |
$ 22,701,000
|
[26] |
|
|
|
|
|
|
|
Investment cost |
|
20,990,000
|
[1],[17] |
23,293,000
|
[2],[26] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 20,844,000
|
[17] |
$ 23,627,000
|
[26] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Valo Health L L C | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.85%
|
|
|
|
3.85%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.45%
|
[7] |
6.45%
|
[11] |
6.45%
|
[7] |
6.45%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.70%
|
[7] |
9.70%
|
[11] |
9.70%
|
[7] |
9.70%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.85%
|
|
|
|
3.85%
|
|
|
|
|
Principal Amount |
|
$ 9,583,000
|
[12],[17] |
$ 11,500,000
|
[14] |
|
|
|
|
|
|
|
Investment cost |
|
9,805,000
|
[1],[12],[17] |
11,547,000
|
[2],[14] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 9,760,000
|
[12],[17] |
$ 11,492,000
|
[14] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Viridian Therapeutics Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
|
|
2026-10
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.20%
|
|
|
|
4.20%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.45%
|
|
|
|
7.45%
|
|
|
|
|
|
|
Principal Amount |
[10],[17],[29] |
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[17],[29] |
2,004,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[29] |
$ 1,969,000
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | X Four Pharmaceuticals Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
8.80%
|
|
|
|
8.80%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.75%
|
[7] |
3.75%
|
[11] |
3.75%
|
[7] |
3.75%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.75%
|
[7] |
8.75%
|
[11] |
8.75%
|
[7] |
8.75%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
8.80%
|
|
|
|
8.80%
|
|
|
|
|
Principal Amount |
|
$ 32,500,000
|
[12],[17],[18] |
$ 32,500,000
|
[14],[33] |
|
|
|
|
|
|
|
Investment cost |
|
33,464,000
|
[1],[12],[17],[18] |
34,140,000
|
[2],[14],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 33,291,000
|
[12],[17],[18] |
$ 34,085,000
|
[14],[33] |
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Yumanity Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-01
|
|
|
|
2024-01
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
5.92%
|
|
|
|
5.92%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.75%
|
|
|
|
8.75%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
5.92%
|
|
|
|
5.92%
|
|
|
|
|
Principal Amount |
|
|
|
$ 12,732,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
13,256,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 13,187,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Center for Breakthrough Medicines Holdings, LLC [Member] | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-05
|
|
|
|
2023-05
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
7.50%
|
|
|
|
7.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.75%
|
|
|
|
8.75%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
7.50%
|
|
|
|
7.50%
|
|
|
|
|
Principal Amount |
|
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[4] |
|
|
5,005,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 5,005,000
|
|
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Floor Rate | enGene, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.25%
|
|
|
|
8.25%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Chemocentryx, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.25%
|
|
|
|
6.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.25%
|
|
|
|
6.25%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Chemocentryx, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.15%
|
|
|
|
7.15%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.15%
|
|
|
|
7.15%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Nabriva Therapeutics | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
9.95%
|
|
|
|
9.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.95%
|
|
|
|
9.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Akero Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.85%
|
|
|
|
5.85%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.85%
|
|
|
|
5.85%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Alladapt Immunotherapeutics Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.30%
|
|
|
|
5.30%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.30%
|
|
|
|
5.30%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Aldeyra Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Applied Genetic Technologies Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
|
6.95%
|
[7] |
6.95%
|
[11] |
6.95%
|
[7] |
6.95%
|
[11] |
|
|
|
Interest Rate and Floor |
|
6.95%
|
[7] |
6.95%
|
[11] |
6.95%
|
[7] |
6.95%
|
[11] |
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | ATAI Life Sciences N.V. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Aveo Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
|
6.95%
|
[7] |
6.95%
|
[11] |
6.95%
|
[7] |
6.95%
|
[11] |
|
|
|
Interest Rate and Floor |
|
6.95%
|
[7] |
6.95%
|
[11] |
6.95%
|
[7] |
6.95%
|
[11] |
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Axsome Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.31%
|
|
|
|
5.31%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.31%
|
|
|
|
5.31%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Bicycle Therapeutics PLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | BiomX, INC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
|
6.55%
|
[7] |
6.55%
|
[11],[27],[28] |
6.55%
|
[7] |
6.55%
|
[11],[27],[28] |
|
|
|
Interest Rate and Floor |
|
6.55%
|
[7] |
6.55%
|
[11],[27],[28] |
6.55%
|
[7] |
6.55%
|
[11],[27],[28] |
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | BridgeBio Pharma, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
2.00%
|
|
|
|
2.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.00%
|
|
|
|
2.00%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Cellarity, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.75%
|
|
|
|
3.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.75%
|
|
|
|
3.75%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Century Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Codiak Biosciences, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Corium, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.75%
|
|
|
|
7.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.75%
|
|
|
|
7.75%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Eloxx Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
|
6.55%
|
[7] |
6.55%
|
[11] |
6.55%
|
[7] |
6.55%
|
[11] |
|
|
|
Interest Rate and Floor |
|
6.55%
|
[7] |
6.55%
|
[11] |
6.55%
|
[7] |
6.55%
|
[11] |
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | enGene, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.35%
|
|
|
|
6.35%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.35%
|
|
|
|
6.35%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Finch Therapeutics Group, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | G1 Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
9.86%
|
|
|
|
9.86%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.86%
|
|
|
|
9.86%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Geron Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.55%
|
|
|
|
6.55%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.55%
|
|
|
|
6.55%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Gritstone Bio, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.75%
|
|
|
|
5.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.75%
|
|
|
|
5.75%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Hibercell, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | HilleVax, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.15%
|
|
|
|
7.15%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.15%
|
|
|
|
7.15%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Iveric Bio Gene Therapy LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.25%
|
|
|
|
4.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.25%
|
|
|
|
4.25%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Locus Biosciences, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Madrigal Pharmaceutical, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.35%
|
|
|
|
5.35%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.35%
|
|
|
|
5.35%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Phathom Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.50%
|
|
|
|
7.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.50%
|
|
|
|
7.50%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Provention Bio, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.60%
|
|
|
|
6.60%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.60%
|
|
|
|
6.60%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Redshift Bioanalytics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.80%
|
|
|
|
3.80%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.80%
|
|
|
|
3.80%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Scynexis, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Seres Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.98%
|
|
|
|
4.98%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.98%
|
|
|
|
4.98%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Tarsus Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.75%
|
|
|
|
4.75%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.75%
|
|
|
|
4.75%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | TG Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.95%
|
|
|
|
5.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.95%
|
|
|
|
5.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Uni Qure B V | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.28%
|
|
|
|
7.28%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.28%
|
|
|
|
7.28%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Unity Biotechnology Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.25%
|
|
|
|
6.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.25%
|
|
|
|
6.25%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Valo Health L L C | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.85%
|
|
|
|
3.85%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.85%
|
|
|
|
3.85%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | Viridian Therapeutics Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.76%
|
|
|
|
4.76%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.76%
|
|
|
|
4.76%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Exit Fee | X Four Pharmaceuticals Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
8.80%
|
|
|
|
8.80%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.80%
|
|
|
|
8.80%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Alladapt Immunotherapeutics Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
10.90%
|
|
|
|
10.90%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.90%
|
|
|
|
10.90%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Aveo Pharmaceuticals, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
15.00%
|
|
|
|
15.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
15.00%
|
|
|
|
15.00%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Axsome Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
10.70%
|
|
|
|
10.70%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.70%
|
|
|
|
10.70%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Bicycle Therapeutics PLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
9.05%
|
|
|
|
9.05%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.05%
|
|
|
|
9.05%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Finch Therapeutics Group, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
8.80%
|
|
|
|
8.80%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.80%
|
|
|
|
8.80%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Gritstone Bio, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
8.65%
|
|
|
|
8.65%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.65%
|
|
|
|
8.65%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | HilleVax, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.05%
|
|
|
|
6.05%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.05%
|
|
|
|
6.05%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Iveric Bio Gene Therapy LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
10.25%
|
|
|
|
10.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.25%
|
|
|
|
10.25%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured | Cap Rate | Viridian Therapeutics Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
8.95%
|
|
|
|
8.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.95%
|
|
|
|
8.95%
|
|
|
|
|
|
|
Drug Discovery & Development | Senior Secured Tranche A [Member] | TG Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11],[27] |
|
|
3.45%
|
|
|
|
3.45%
|
|
|
|
|
Drug Discovery & Development | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,056,335,000
|
[1] |
$ 936,457,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,052,244,000
|
|
935,964,000
|
|
|
|
|
|
|
|
|
Drug Delivery |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
90,000
|
|
368,000
|
|
|
|
|
|
|
|
|
Drug Delivery | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,638,000
|
[1] |
3,638,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
305,000
|
|
|
|
|
|
|
|
|
Drug Delivery | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
465,000
|
[1] |
465,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
0
|
|
63,000
|
|
|
|
|
|
|
|
|
Drug Delivery | AcelRx Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,329,000
|
[1],[5] |
1,329,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 37,000
|
[5] |
$ 99,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 10, 2018
|
[5] |
Dec. 10, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
176,730
|
[5] |
176,730
|
[6] |
176,730
|
[5] |
176,730
|
[6] |
|
|
|
Drug Delivery | Aytu BioScience, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500,000
|
[1],[5] |
$ 1,500,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 3,000
|
[5] |
$ 18,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 28, 2014
|
[5] |
Mar. 28, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
13,600
|
[5] |
13,600
|
[6] |
13,600
|
[5] |
13,600
|
[6] |
|
|
|
Drug Delivery | BioQ Pharma Incorporated | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500,000
|
[1] |
$ 500,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 43,000
|
|
$ 168,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 08, 2015
|
[5] |
Dec. 08, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
165,000
|
|
165,000
|
|
165,000
|
|
165,000
|
|
|
|
|
Drug Delivery | BioQ Pharma Incorporated | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[1] |
$ 1,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 62,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 27, 2014
|
[5] |
Oct. 27, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
459,183
|
|
459,183
|
|
459,183
|
|
459,183
|
|
|
|
|
Drug Delivery | PDS Biotechnology Corporation | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
$ 309,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 7,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 06, 2015
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
2,498
|
|
|
|
2,498
|
|
|
|
|
|
|
Drug Delivery | PDS Biotechnology Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 390,000
|
[1],[5] |
$ 390,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[5] |
$ 1,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 28, 2014
|
[5] |
Aug. 28, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
3,929
|
[5] |
3,929
|
[6] |
3,929
|
[5] |
3,929
|
[6] |
|
|
|
Drug Delivery | Aerami Therapeutics Holdings, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 74,000
|
[1] |
$ 74,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 30, 2015
|
[5] |
Sep. 30, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
110,882
|
|
110,882
|
|
110,882
|
|
110,882
|
|
|
|
|
Drug Delivery | PDS Biotechnology Corporation (p.k.a. Edge Therapeutics, Inc.) | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 309,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 20,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 06, 2015
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
2,498
|
|
|
|
2,498
|
|
|
|
|
Healthcare Services Other |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 203,599,000
|
|
$ 121,003,000
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
6,782,000
|
[1] |
6,781,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
3,198,000
|
|
7,364,000
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
697,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
521,000
|
|
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
156,619,000
|
[1] |
113,724,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
155,925,000
|
|
113,639,000
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
43,955,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
43,955,000
|
|
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Carbon Health Technologies, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,688,000
|
[1] |
1,687,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 836,000
|
|
$ 1,864,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 30, 2021
|
[5] |
Mar. 30, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
217,880
|
|
217,880
|
|
217,880
|
|
217,880
|
|
|
|
|
Healthcare Services Other | Elation Health, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 583,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 501,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 12, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
362,837
|
|
|
|
362,837
|
|
|
|
|
|
|
Healthcare Services Other | 23andMe, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 5,094,000
|
[1],[5] |
$ 5,094,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,362,000
|
[5] |
$ 5,500,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 11, 2019
|
[5] |
Mar. 11, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
825,732
|
[5] |
825,732
|
[6] |
825,732
|
[5] |
825,732
|
[6] |
|
|
|
Healthcare Services Other | Vida Health, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 114,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 28, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
100,618
|
|
|
|
100,618
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Better Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
|
|
|
Investment Interest Rate |
|
|
|
5.95%
|
|
|
|
5.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
|
5.70%
|
[7] |
5.70%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
|
8.95%
|
[7] |
8.95%
|
|
|
|
|
Interest Rate and Floor |
|
|
|
5.95%
|
|
|
|
5.95%
|
|
|
|
|
Principal Amount |
|
$ 12,000,000
|
[31] |
$ 8,000,000
|
[15],[32] |
|
|
|
|
|
|
|
Investment cost |
|
12,093,000
|
[1],[31] |
7,966,000
|
[2],[15],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 11,996,000
|
[31] |
$ 7,966,000
|
[15],[32] |
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Blue Sprig Pediatrics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.00%
|
[7] |
5.00%
|
|
5.00%
|
[7] |
5.00%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
6.00%
|
[7] |
6.00%
|
|
6.00%
|
[7] |
6.00%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
4.45%
|
|
|
|
4.45%
|
|
|
|
|
|
|
Principal Amount |
|
$ 40,949,000
|
[9],[10],[12],[17] |
$ 25,022,000
|
[15],[20] |
|
|
|
|
|
|
|
Investment cost |
|
40,403,000
|
[1],[9],[10],[12],[17] |
24,653,000
|
[2],[15],[20] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 39,332,000
|
[9],[10],[12],[17] |
$ 24,653,000
|
[15],[20] |
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Carbon Health Technologies, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
|
|
|
Investment Interest Rate |
|
|
|
4.61%
|
|
|
|
4.61%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.60%
|
[7] |
5.60%
|
|
5.60%
|
[7] |
5.60%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
8.85%
|
[7] |
8.85%
|
|
8.85%
|
[7] |
8.85%
|
|
|
|
|
Interest Rate and Floor |
|
|
|
4.61%
|
|
|
|
4.61%
|
|
|
|
|
Principal Amount |
|
$ 46,125,000
|
[8],[10],[12],[17],[18] |
$ 46,125,000
|
[15],[23] |
|
|
|
|
|
|
|
Investment cost |
|
46,399,000
|
[1],[8],[10],[12],[17],[18] |
45,964,000
|
[2],[15],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 46,158,000
|
[8],[10],[12],[17],[18] |
$ 45,964,000
|
[15],[23] |
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Equality Health, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-02
|
|
2026-02
|
|
2026-02
|
|
2026-02
|
|
|
|
|
Investment Interest Rate |
|
|
|
1.55%
|
|
|
|
1.55%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.25%
|
[7] |
6.25%
|
|
6.25%
|
[7] |
6.25%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
9.50%
|
[7] |
9.50%
|
|
9.50%
|
[7] |
9.50%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.55%
|
|
|
|
1.55%
|
|
|
|
|
|
|
Interest Rate and Floor |
|
|
|
1.55%
|
|
|
|
1.55%
|
|
|
|
|
Principal Amount |
|
$ 53,388,000
|
[9],[18] |
$ 35,444,000
|
[15],[20],[33] |
|
|
|
|
|
|
|
Investment cost |
|
52,928,000
|
[1],[9],[18] |
35,141,000
|
[2],[15],[20],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 53,644,000
|
[9],[18] |
35,056,000
|
[15],[20],[33] |
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Elation Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
|
|
2026-03
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.25%
|
|
|
|
4.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.00%
|
|
|
|
9.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.95%
|
|
|
|
1.95%
|
|
|
|
|
|
|
Principal Amount |
[8],[10] |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8],[10] |
4,796,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[10] |
$ 4,795,000
|
|
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Oak Street Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
2.45%
|
|
|
|
2.45%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.95%
|
|
|
|
7.95%
|
|
|
|
|
|
|
Principal Amount |
[10],[29] |
$ 44,250,000
|
|
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Oak Street Health, Inc. | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
|
|
|
2027-10
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.00%
|
|
|
|
1.00%
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29] |
$ 43,955,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29] |
$ 43,955,000
|
|
|
|
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Exit Fee | Better Therapeutics, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.95%
|
|
|
|
5.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.95%
|
|
|
|
5.95%
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Exit Fee | Carbon Health Technologies, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.61%
|
|
|
|
4.61%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.61%
|
|
|
|
4.61%
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Exit Fee | Elation Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Healthcare Services Other | Senior Secured | Cap Rate | Oak Street Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
9.45%
|
|
|
|
9.45%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.45%
|
|
|
|
9.45%
|
|
|
|
|
|
|
Healthcare Services Other | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 200,574,000
|
[1] |
113,724,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
199,880,000
|
|
113,639,000
|
|
|
|
|
|
|
|
|
Information Services |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
59,735,000
|
|
74,417,000
|
|
|
|
|
|
|
|
|
Information Services | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
4,440,000
|
[1] |
4,440,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
7,579,000
|
|
9,414,000
|
|
|
|
|
|
|
|
|
Information Services | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
680,000
|
[1] |
645,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
416,000
|
|
557,000
|
|
|
|
|
|
|
|
|
Information Services | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
52,386,000
|
[1] |
64,773,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
51,740,000
|
|
64,446,000
|
|
|
|
|
|
|
|
|
Information Services | Capella Space Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
207,000
|
[1],[31] |
207,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 50,000
|
[31] |
$ 139,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 21, 2021
|
[5] |
Oct. 21, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
176,200
|
[31] |
176,200
|
[32] |
176,200
|
[31] |
176,200
|
[32] |
|
|
|
Information Services | Signal Media Limited | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 21,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 29, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[29],[30] |
94,857
|
|
|
|
94,857
|
|
|
|
|
|
|
Information Services | Yipit, LLC | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,825,000
|
[1] |
$ 3,825,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,648,000
|
|
$ 3,825,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 30, 2021
|
[5] |
Dec. 30, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
41,021
|
|
41,021
|
|
41,021
|
|
41,021
|
|
|
|
|
Information Services | Planet Labs, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 615,000
|
[1],[5] |
$ 615,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,975,000
|
[5] |
$ 3,369,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 21, 2019
|
[5] |
Jun. 21, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
547,880
|
[5] |
547,880
|
|
547,880
|
[5] |
547,880
|
|
|
|
|
Information Services | Zeta Global Corp. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[1],[5] |
$ 0
|
[2],[6],[34] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,956,000
|
[5] |
$ 2,220,000
|
[6],[34] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 20, 2007
|
[5] |
Nov. 20, 2007
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
295,861
|
[5] |
295,861
|
[6],[34] |
295,861
|
[5] |
295,861
|
[6],[34] |
|
|
|
Information Services | I N M O B I Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 82,000
|
[1],[29],[30] |
$ 82,000
|
[2],[27] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[29],[30] |
$ 0
|
[27] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 19, 2014
|
[5] |
Nov. 19, 2014
|
[6],[27] |
|
|
|
|
|
|
|
Shares | shares |
|
65,587
|
[29],[30] |
65,587
|
[27] |
65,587
|
[29],[30] |
65,587
|
[27] |
|
|
|
Information Services | NetBase Solutions, Inc. | Warrant Investment | Preferred Series 1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 356,000
|
[1] |
$ 356,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 345,000
|
|
$ 418,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 22, 2017
|
[5] |
Aug. 22, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
60,000
|
|
60,000
|
|
60,000
|
|
60,000
|
|
|
|
|
Information Services | Senior Secured | Capella Space Corp. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-11
|
|
2024-11
|
|
2024-11
|
|
2024-11
|
|
|
|
|
Investment Interest Rate |
|
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.00%
|
[7] |
5.00%
|
|
5.00%
|
[7] |
5.00%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
8.25%
|
[7] |
8.25%
|
|
8.25%
|
[7] |
8.25%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.10%
|
[7] |
1.10%
|
|
1.10%
|
[7] |
1.10%
|
|
|
|
|
Interest Rate and Floor |
|
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Principal Amount |
|
$ 20,193,000
|
[8],[9],[31] |
$ 20,025,000
|
[20],[23],[32] |
|
|
|
|
|
|
|
Investment cost |
|
20,302,000
|
[1],[8],[9],[31] |
19,751,000
|
[2],[20],[23],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 20,219,000
|
[8],[9],[31] |
$ 19,424,000
|
[20],[23],[32] |
|
|
|
|
|
|
|
Information Services | Senior Secured | Signal Media Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
|
|
|
2025-06
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.00%
|
|
|
|
9.00%
|
|
|
|
|
|
|
Principal Amount |
[10],[29],[30] |
$ 750,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[29],[30] |
739,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[29],[30] |
$ 739,000
|
|
|
|
|
|
|
|
|
|
|
Information Services | Senior Secured | Yipit, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.08%
|
[7] |
9.08%
|
|
9.08%
|
[7] |
9.08%
|
|
|
|
|
Investment, Interest Rate, Floor |
|
10.08%
|
[7] |
10.08%
|
|
10.08%
|
[7] |
10.08%
|
|
|
|
|
Principal Amount |
|
$ 31,875,000
|
[10],[13] |
$ 45,900,000
|
[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
31,345,000
|
[1],[10],[13] |
45,022,000
|
[2],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 30,782,000
|
[10],[13] |
45,022,000
|
[15],[16] |
|
|
|
|
|
|
|
Information Services | Senior Secured | Exit Fee | Capella Space Corp. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.00%
|
|
|
|
7.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.00%
|
|
|
|
7.00%
|
|
|
|
|
|
|
Information Services | Senior Secured | Exit Fee | Signal Media Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.45%
|
|
|
|
3.45%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.45%
|
|
|
|
3.45%
|
|
|
|
|
|
|
Information Services | Senior Secured | Cap Rate | Signal Media Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
12.00%
|
|
|
|
12.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
12.00%
|
|
|
|
12.00%
|
|
|
|
|
|
|
Information Services | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 52,386,000
|
[1] |
64,773,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
51,740,000
|
|
64,446,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
489,968,000
|
|
395,506,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
22,058,000
|
[1] |
22,151,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
15,377,000
|
|
35,331,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
6,110,000
|
[1] |
4,992,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
5,800,000
|
|
10,212,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
82,481,000
|
[1] |
22,164,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
82,481,000
|
|
22,164,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
384,097,000
|
[1] |
341,001,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
365,957,000
|
|
327,799,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
21,252,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
20,354,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Fulfil Solutions Inc [Member] | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
325,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 199,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jul. 29, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
84,995
|
|
|
|
84,995
|
|
|
|
|
|
|
Internet Consumer And Business Services | SeatGeek, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 842,000
|
[1],[19] |
842,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,692,000
|
[19] |
$ 1,140,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 12, 2019
|
[5] |
Jun. 12, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,379,761
|
[19] |
1,379,761
|
|
1,379,761
|
[19] |
1,379,761
|
|
|
|
|
Internet Consumer And Business Services | Carwow LTD | Equity | Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,151,000
|
[1],[29],[30] |
$ 1,151,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 216,000
|
[29],[30] |
$ 608,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 15, 2021
|
[5] |
Dec. 15, 2021
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
199,742
|
[29],[30] |
199,742
|
[27],[28] |
199,742
|
[29],[30] |
199,742
|
[27],[28] |
|
|
|
Internet Consumer And Business Services | Carwow LTD | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 164,000
|
[1],[29],[30] |
$ 164,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 33,000
|
[29],[30] |
$ 160,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 14, 2021
|
[5] |
Dec. 14, 2021
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
174,163
|
[29],[30] |
174,163
|
[27],[28] |
174,163
|
[29],[30] |
174,163
|
[27],[28] |
|
|
|
Internet Consumer And Business Services | Convoy, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[19] |
$ 974,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[19] |
$ 582,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 30, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[19] |
165,456
|
|
|
|
165,456
|
|
|
|
|
|
|
Internet Consumer And Business Services | Rhino Labs Incorporation | Equity | Preferred Series B-2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 866,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jan. 24, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
7,063
|
|
|
|
7,063
|
|
|
|
|
|
|
Internet Consumer And Business Services | Rhino Labs Incorporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 470,000
|
[1],[31] |
$ 470,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 344,000
|
[31] |
$ 77,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 12, 2021
|
[5] |
Mar. 12, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
13,106
|
[31] |
13,106
|
[32] |
13,106
|
[31] |
13,106
|
[32] |
|
|
|
Internet Consumer And Business Services | Skyword, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 83,000
|
[1] |
$ 83,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,000
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 23, 2019
|
[5] |
Aug. 23, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
444,444
|
|
444,444
|
|
444,444
|
|
444,444
|
|
|
|
|
Internet Consumer And Business Services | Tectura Corporation | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 900,000
|
[1] |
$ 900,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Shares | shares |
|
415,994,863
|
|
415,994,863
|
|
415,994,863
|
|
415,994,863
|
|
|
|
|
Internet Consumer And Business Services | Tectura Corporation | Equity | Preferred Series BB |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[1],[24] |
$ 0
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[24] |
$ 0
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 06, 2016
|
[5] |
Jun. 06, 2016
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
1,000,000
|
[24] |
1,000,000
|
[25] |
1,000,000
|
[24] |
1,000,000
|
[25] |
|
|
|
Internet Consumer And Business Services | Tectura Corporation | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 900,000
|
[1],[24] |
$ 900,000
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[24] |
$ 0
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 23, 2018
|
[5] |
May 23, 2018
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
414,994,863
|
[24] |
414,994,863
|
[25] |
414,994,863
|
[24] |
414,994,863
|
[25] |
|
|
|
Internet Consumer And Business Services | Tectura Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 31,953,000
|
|
$ 31,953,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
21,513,000
|
[1] |
21,513,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
8,318,000
|
|
8,269,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Thumbtack, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
844,000
|
[1] |
552,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 459,000
|
|
$ 786,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 01, 2018
|
[5] |
May 01, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
267,225
|
|
190,953
|
|
267,225
|
|
190,953
|
|
|
|
|
Internet Consumer And Business Services | Veem, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 126,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 48,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
98,428
|
|
|
|
98,428
|
|
|
|
|
|
|
Internet Consumer And Business Services | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 10,041,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
10,022,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Worldremit Group Limited | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
155,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 405,000
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
79,083
|
|
|
|
79,083
|
|
|
|
|
|
|
Internet Consumer And Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[19],[29],[30] |
$ 129,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[19],[29],[30] |
$ 399,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Feb. 11, 2021
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[19],[29],[30] |
77,215
|
|
|
|
77,215
|
|
|
|
|
|
|
Internet Consumer And Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[19],[29],[30] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[19],[29],[30] |
$ 6,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Aug. 27, 2021
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[19],[29],[30] |
1,868
|
|
|
|
1,868
|
|
|
|
|
|
|
Internet Consumer And Business Services | Houzz, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20,000
|
[1] |
$ 20,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,000
|
|
$ 116,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 29, 2019
|
[5] |
Oct. 29, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
529,661
|
|
529,661
|
|
529,661
|
|
529,661
|
|
|
|
|
Internet Consumer And Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Series Seed |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[35] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[35] |
|
|
$ 1,120,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[35] |
|
|
Mar. 24, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
[35] |
|
|
872,797
|
|
|
|
872,797
|
|
|
|
|
Internet Consumer And Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Note |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,000,000
|
[1],[36] |
$ 3,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 3,000,000
|
[36] |
$ 3,000,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 24, 2021
|
[5] |
Mar. 24, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
3
|
[36] |
3
|
|
3
|
[36] |
3
|
|
|
|
|
Internet Consumer And Business Services | Contentful Global, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 638,000
|
[1] |
$ 638,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 924,000
|
|
$ 1,894,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
149,500
|
|
149,500
|
|
149,500
|
|
149,500
|
|
|
|
|
Internet Consumer And Business Services | Contentful Global, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500,000
|
[1],[29],[30] |
$ 500,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 685,000
|
[29],[30] |
$ 1,388,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 20, 2018
|
[5] |
Nov. 20, 2018
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
108,500
|
[29],[30] |
108,500
|
[27],[28] |
108,500
|
[29],[30] |
108,500
|
[27],[28] |
|
|
|
Internet Consumer And Business Services | Contentful Global, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 138,000
|
[1],[29],[30] |
$ 138,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 239,000
|
[29],[30] |
$ 506,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 22, 2020
|
[5] |
Dec. 22, 2020
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
41,000
|
[29],[30] |
41,000
|
[27],[28] |
41,000
|
[29],[30] |
41,000
|
[27],[28] |
|
|
|
Internet Consumer And Business Services | DoorDash, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 945,000
|
[1],[5] |
$ 945,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 4,055,000
|
[5] |
$ 12,209,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 20, 2018
|
[5] |
Dec. 20, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
81,996
|
[5] |
81,996
|
[6] |
81,996
|
[5] |
81,996
|
[6] |
|
|
|
Internet Consumer And Business Services | Lyft Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 5,263,000
|
[1],[5] |
$ 5,263,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,327,000
|
[5] |
$ 4,305,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 26, 2018
|
[5] |
Dec. 26, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
100,738
|
[5] |
100,738
|
[6] |
100,738
|
[5] |
100,738
|
[6] |
|
|
|
Internet Consumer And Business Services | Nerdy Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1],[5],[22] |
$ 1,000,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 209,000
|
[5],[22] |
$ 450,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 17, 2021
|
[5] |
Sep. 17, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
100,000
|
[5],[22] |
100,000
|
[6] |
100,000
|
[5],[22] |
100,000
|
[6] |
|
|
|
Internet Consumer And Business Services | Nextdoor.com, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,854,000
|
[1],[5] |
$ 4,854,000
|
[2],[6],[34] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,844,000
|
[5] |
$ 6,624,000
|
[6],[34] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 01, 2018
|
[5] |
Aug. 01, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,019,255
|
[5] |
1,019,255
|
[6],[34] |
1,019,255
|
[5] |
1,019,255
|
[6],[34] |
|
|
|
Internet Consumer And Business Services | OfferUp, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,295,000
|
[1] |
$ 2,295,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 577,000
|
|
$ 2,471,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
394,790
|
|
394,790
|
|
394,790
|
|
394,790
|
|
|
|
|
Internet Consumer And Business Services | OfferUp, Inc. | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,663,000
|
[1] |
$ 1,663,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 418,000
|
|
$ 1,791,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 25, 2016
|
[5] |
Oct. 25, 2016
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
286,080
|
|
286,080
|
|
286,080
|
|
286,080
|
|
|
|
|
Internet Consumer And Business Services | OfferUp, Inc. | Equity | Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 632,000
|
[1] |
$ 632,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 159,000
|
|
$ 680,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 25, 2016
|
[5] |
Oct. 25, 2016
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
108,710
|
|
108,710
|
|
108,710
|
|
108,710
|
|
|
|
|
Internet Consumer And Business Services | Oportun | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 577,000
|
[1],[5] |
$ 577,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 211,000
|
[5] |
$ 980,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 28, 2013
|
[5] |
Jun. 28, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
48,365
|
[5] |
48,365
|
[6] |
48,365
|
[5] |
48,365
|
[6] |
|
|
|
Internet Consumer And Business Services | Reischling Press, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 15,000
|
[1] |
$ 15,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 31, 2020
|
[5] |
Jul. 31, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,163
|
|
1,163
|
|
1,163
|
|
1,163
|
|
|
|
|
Internet Consumer And Business Services | Savage X Holding, LLC | Equity | Class A Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 13,000
|
[1] |
$ 13,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 179,000
|
|
$ 71,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 30, 2010
|
[5] |
Apr. 30, 2010
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
42,137
|
|
42,137
|
|
42,137
|
|
42,137
|
|
|
|
|
Internet Consumer And Business Services | Savage X Holding, LLC | Warrant Investment | Class A Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 875,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 27, 2014
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
|
|
206,185
|
|
|
|
|
|
|
Internet Consumer And Business Services | TFG Holding, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 89,000
|
[1] |
$ 89,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 95,000
|
|
$ 216,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 30, 2010
|
[5] |
Apr. 30, 2010
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
|
|
|
Internet Consumer And Business Services | TFG Holding, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 17,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 27, 2014
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
|
|
206,185
|
|
|
|
|
|
|
Internet Consumer And Business Services | Uber Technologies, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 318,000
|
[1],[5] |
$ 318,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 874,000
|
[5] |
$ 1,383,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 01, 2020
|
[5] |
Dec. 01, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
32,991
|
[5] |
32,991
|
[6] |
32,991
|
[5] |
32,991
|
[6] |
|
|
|
Internet Consumer And Business Services | Snagajobcom Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 860,000
|
[1] |
$ 860,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 258,000
|
|
$ 382,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
|
|
|
Internet Consumer And Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 782,000
|
[1],[18] |
$ 782,000
|
[2],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 120,000
|
[18] |
$ 171,000
|
[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 30, 2016
|
[5] |
Jun. 30, 2016
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,800,000
|
[18] |
1,800,000
|
[33] |
1,800,000
|
[18] |
1,800,000
|
[33] |
|
|
|
Internet Consumer And Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 62,000
|
[1],[18] |
$ 62,000
|
[2],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 69,000
|
[18] |
$ 90,000
|
[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 01, 2018
|
[5] |
Aug. 01, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,211,537
|
[18] |
1,211,537
|
[33] |
1,211,537
|
[18] |
1,211,537
|
[33] |
|
|
|
Internet Consumer And Business Services | Snagajobcom Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 16,000
|
[1],[18] |
$ 16,000
|
[2],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 69,000
|
[18] |
$ 121,000
|
[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 20, 2020
|
[5] |
Apr. 20, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
600,000
|
[18] |
600,000
|
[33] |
600,000
|
[18] |
600,000
|
[33] |
|
|
|
Internet Consumer And Business Services | Aria Systems, Inc. | Warrant Investment | Preferred Series G |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 74,000
|
[1] |
$ 74,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 22, 2015
|
[5] |
May 22, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
231,535
|
|
231,535
|
|
231,535
|
|
231,535
|
|
|
|
|
Internet Consumer And Business Services | Cloudpay, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 54,000
|
[1],[29],[30] |
$ 54,000
|
[2],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 310,000
|
[29],[30] |
$ 348,000
|
[27],[28] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 10, 2018
|
[5] |
Apr. 10, 2018
|
[6],[27],[28] |
|
|
|
|
|
|
|
Shares | shares |
|
6,763
|
[29],[30] |
6,763
|
[27],[28] |
6,763
|
[29],[30] |
6,763
|
[27],[28] |
|
|
|
Internet Consumer And Business Services | First Insight, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 95,000
|
[1] |
$ 96,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 35,000
|
|
$ 105,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 10, 2018
|
[5] |
May 10, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
75,917
|
|
75,917
|
|
75,917
|
|
75,917
|
|
|
|
|
Internet Consumer And Business Services | Landing Holdings Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 116,000
|
[1],[31] |
$ 116,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 117,000
|
[31] |
$ 141,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 12, 2021
|
[5] |
Mar. 12, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
11,806
|
[31] |
11,806
|
[32] |
11,806
|
[31] |
11,806
|
[32] |
|
|
|
Internet Consumer And Business Services | Lendio, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39,000
|
[1] |
$ 39,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 35,000
|
|
$ 84,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 29, 2019
|
[5] |
Mar. 29, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
127,032
|
|
127,032
|
|
127,032
|
|
127,032
|
|
|
|
|
Internet Consumer And Business Services | RumbleON, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 88,000
|
[1],[5] |
$ 88,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,000
|
[5] |
$ 33,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 30, 2018
|
[5] |
Apr. 30, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
5,139
|
[5] |
5,139
|
[6] |
5,139
|
[5] |
5,139
|
[6] |
|
|
|
Internet Consumer And Business Services | ShareThis, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 547,000
|
[1] |
$ 547,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 14, 2012
|
[5] |
Dec. 14, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
493,502
|
|
493,502
|
|
493,502
|
|
493,502
|
|
|
|
|
Internet Consumer And Business Services | The Faction Group LLC | Warrant Investment | Preferred Series AA |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 234,000
|
[1],[7] |
$ 234,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 387,000
|
|
$ 650,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 03, 2014
|
[5] |
Nov. 03, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
8,076
|
|
8,076
|
|
8,076
|
|
8,076
|
|
|
|
|
Internet Consumer And Business Services | Xometry, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[6] |
|
|
$ 47,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[6] |
|
|
$ 3,038,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
May 09, 2018
|
|
|
|
|
|
|
|
|
Shares | shares |
[6] |
|
|
87,784
|
|
|
|
87,784
|
|
|
|
|
Internet Consumer And Business Services | Interactions Corporation | Warrant Investment | Series G Three Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 204,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 505,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jun. 16, 2015
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
68,187
|
|
|
|
68,187
|
|
|
|
|
Internet Consumer And Business Services | Brigade Group, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 93,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Mar. 01, 2013
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
9,023
|
|
|
|
9,023
|
|
|
|
|
Internet Consumer And Business Services | Logic Source | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 30,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 210,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Mar. 21, 2016
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
79,625
|
|
|
|
79,625
|
|
|
|
|
Internet Consumer And Business Services | Tapjoy, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 317,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 443,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jul. 01, 2014
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
748,670
|
|
|
|
748,670
|
|
|
|
|
Internet Consumer And Business Services | Zepz (p.k.a. Worldremit Group Limited) | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 155,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 1,987,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
79,083
|
|
|
|
79,083
|
|
|
|
|
Internet Consumer And Business Services | Zepz (p.k.a. Worldremit Group Limited) | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[27],[28] |
|
|
$ 129,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[21],[27],[28] |
|
|
$ 1,962,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27],[28] |
|
|
Feb. 11, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
[21],[27],[28] |
|
|
77,215
|
|
|
|
77,215
|
|
|
|
|
Internet Consumer And Business Services | Zepz (p.k.a. Worldremit Group Limited) | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[27],[28] |
|
|
$ 26,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[21],[27],[28] |
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[27],[28] |
|
|
Aug. 27, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
[21],[27],[28] |
|
|
1,868
|
|
|
|
1,868
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Salary.com, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
|
|
2027-09
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.00%
|
|
|
|
8.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.00%
|
|
|
|
9.00%
|
|
|
|
|
|
|
Investment cost |
[1],[13] |
$ 17,640,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13] |
$ 17,640,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | SeatGeek, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-06
|
|
|
|
2023-06
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
10.50%
|
|
|
|
10.50%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
0.50%
|
|
|
|
0.50%
|
|
|
|
|
|
|
Principal Amount |
[9],[12],[17],[18],[19] |
$ 60,838,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[12],[17],[18],[19] |
60,529,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[12],[17],[18],[19] |
$ 60,529,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | SeatGeek, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2023-06
|
|
2026-05
|
|
2023-06
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
7.00%
|
[7] |
5.00%
|
[11] |
7.00%
|
[7] |
5.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.50%
|
[7] |
10.50%
|
[11] |
10.50%
|
[7] |
10.50%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
0.50%
|
[7] |
0.50%
|
[11] |
0.50%
|
[7] |
0.50%
|
[11] |
|
|
|
Principal Amount |
|
$ 25,040,000
|
[9],[12],[17],[18],[19] |
$ 60,607,000
|
[20] |
|
|
|
|
|
|
|
Investment cost |
|
24,869,000
|
[1],[9],[12],[17],[18],[19] |
59,983,000
|
[2],[20] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 25,591,000
|
[9],[12],[17],[18],[19] |
$ 60,316,000
|
[20] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | App Direct Incorporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-04
|
|
2024-08
|
|
2026-04
|
|
2024-08
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
7.95%
|
|
|
|
7.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.50%
|
[7] |
5.90%
|
[11] |
5.50%
|
[7] |
5.90%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.75%
|
[7] |
9.15%
|
[11] |
8.75%
|
[7] |
9.15%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
7.95%
|
|
|
|
7.95%
|
|
|
|
|
Principal Amount |
|
$ 30,790,000
|
[10],[18] |
$ 30,790,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
31,733,000
|
[1],[10],[18] |
31,416,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 31,991,000
|
[10],[18] |
$ 32,248,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Carwow LTD | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.70%
|
[7] |
4.70%
|
[11],[27],[28] |
4.70%
|
[7] |
4.70%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
7.95%
|
[7] |
7.95%
|
[11],[27],[28] |
7.95%
|
[7] |
7.95%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.45%
|
[7] |
1.45%
|
[11],[27],[28] |
1.45%
|
[7] |
1.45%
|
[11],[27],[28] |
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Principal Amount |
|
$ 21,021,000
|
[9],[29],[30] |
|
|
£ 18,798
|
[9],[29],[30] |
£ 21,250
|
[20],[27],[28] |
|
|
|
Investment cost |
|
$ 25,845,000
|
[1],[9],[29],[30] |
$ 28,632,000
|
[2],[20],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
[20],[27],[28] |
|
|
$ 28,632,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Convoy, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
|
|
2026-03
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.20%
|
|
|
|
3.20%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
6.45%
|
|
|
|
6.45%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.95%
|
|
|
|
1.95%
|
|
|
|
|
|
|
Principal Amount |
[8],[9],[19] |
$ 73,623,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8],[9],[19] |
72,447,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[19] |
$ 73,092,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Jobandtalent USA, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
|
|
2025-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.86%
|
|
|
|
8.86%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.75%
|
|
|
|
9.75%
|
|
|
|
|
|
|
Principal Amount |
[29],[30] |
$ 14,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
13,802,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 13,865,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Nextroll, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-07
|
|
2022-06
|
|
2023-07
|
|
2022-06
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.50%
|
|
|
|
3.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
3.75%
|
|
|
|
3.75%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
7.00%
|
|
|
|
7.00%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11] |
|
|
2.95%
|
|
|
|
2.95%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.50%
|
|
|
|
3.50%
|
|
|
|
|
Principal Amount |
|
$ 22,046,000
|
[9],[18] |
$ 21,555,000
|
[20],[23],[33] |
|
|
|
|
|
|
|
Investment cost |
|
21,952,000
|
[1],[9],[18] |
22,164,000
|
[2],[20],[23],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,952,000
|
[9],[18] |
$ 22,164,000
|
[20],[23],[33] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Nextroll, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.75%
|
|
|
|
7.75%
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.75%
|
|
|
|
3.75%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
2.95%
|
|
|
|
2.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.75%
|
|
|
|
7.75%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Rhino Labs Incorporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-03
|
|
2024-03
|
|
2024-03
|
|
2024-03
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.50%
|
[7] |
5.50%
|
[11] |
5.50%
|
[7] |
5.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.75%
|
[7] |
8.75%
|
[11] |
8.75%
|
[7] |
8.75%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
2.25%
|
[7] |
2.25%
|
[11] |
2.25%
|
[7] |
2.25%
|
[11] |
|
|
|
Principal Amount |
|
$ 16,407,000
|
[9],[31] |
$ 16,136,000
|
[20],[32] |
|
|
|
|
|
|
|
Investment cost |
|
16,180,000
|
[1],[9],[31] |
15,765,000
|
[2],[20],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 16,331,000
|
[9],[31] |
$ 15,876,000
|
[20],[32] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | R V Share Limited Liability Company | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.50%
|
[7] |
5.50%
|
[11] |
5.50%
|
[7] |
5.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
6.50%
|
[7] |
6.50%
|
[11] |
6.50%
|
[7] |
6.50%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
4.00%
|
[7] |
4.00%
|
[11] |
4.00%
|
[7] |
4.00%
|
[11] |
|
|
|
Principal Amount |
|
$ 20,489,000
|
[9],[10],[17],[31] |
$ 15,000,000
|
[15],[32] |
|
|
|
|
|
|
|
Investment cost |
|
20,138,000
|
[1],[9],[10],[17],[31] |
14,701,000
|
[2],[15],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 20,130,000
|
[9],[10],[17],[31] |
$ 14,701,000
|
[15],[32] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Skyword, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.88%
|
[7] |
3.88%
|
[11] |
3.88%
|
[7] |
3.88%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.38%
|
[7] |
9.38%
|
[11] |
9.38%
|
[7] |
9.38%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.90%
|
[7] |
1.90%
|
[11] |
1.90%
|
[7] |
1.90%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Principal Amount |
|
$ 12,607,000
|
[9],[17] |
$ 12,426,000
|
[20] |
|
|
|
|
|
|
|
Investment cost |
|
12,922,000
|
[1],[9],[17] |
12,665,000
|
[2],[20] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 12,708,000
|
[9],[17] |
$ 12,521,000
|
[20] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Thumbtack, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-04
|
|
2023-09
|
|
2026-04
|
|
2023-09
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.95%
|
[7] |
3.45%
|
[11] |
4.95%
|
[7] |
3.45%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11] |
8.95%
|
[7] |
8.95%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.50%
|
[7] |
1.50%
|
[11] |
1.50%
|
[7] |
1.50%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Principal Amount |
|
$ 10,065,000
|
[9],[10],[18] |
$ 25,618,000
|
[20],[33] |
|
|
|
|
|
|
|
Investment cost |
|
9,985,000
|
[1],[9],[10],[18] |
25,965,000
|
[2],[20],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
9,938,000
|
[9],[10],[18] |
$ 26,372,000
|
[20],[33] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 9,891,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Worldremit Group Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
|
|
|
Investment Interest Rate |
[11],[27],[28] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.25%
|
[7] |
9.25%
|
[11],[27],[28] |
9.25%
|
[7] |
9.25%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
10.25%
|
[7] |
10.25%
|
[11],[27],[28] |
10.25%
|
[7] |
10.25%
|
[11],[27],[28] |
|
|
|
Interest Rate and Floor |
[11],[27],[28] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Principal Amount |
|
$ 94,500,000
|
[8],[12],[18],[19],[29],[30] |
$ 103,000,000
|
[21],[23],[27],[28],[33] |
|
|
|
|
|
|
|
Investment cost |
|
94,115,000
|
[1],[8],[12],[18],[19],[29],[30] |
101,674,000
|
[2],[21],[23],[27],[28],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 92,293,000
|
[8],[12],[18],[19],[29],[30] |
$ 100,472,000
|
[21],[23],[27],[28],[33] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | E Pay Policy Holdings L L C | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-12
|
|
|
|
2024-12
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
8.50%
|
|
|
|
8.50%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
9.50%
|
|
|
|
9.50%
|
|
|
|
|
Principal Amount |
[14],[15] |
|
|
$ 8,169,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[14],[15] |
|
|
8,011,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14],[15] |
|
|
$ 7,967,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Logic Source | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.93%
|
|
|
|
8.93%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.93%
|
|
|
|
9.93%
|
|
|
|
|
|
|
Principal Amount |
[10] |
$ 13,300,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10] |
13,017,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10] |
$ 13,017,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | App Direct Incorporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
9.70%
|
|
|
|
9.70%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.70%
|
|
|
|
9.70%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Carwow LTD | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Convoy, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.55%
|
|
|
|
4.55%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.55%
|
|
|
|
4.55%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Jobandtalent USA, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Nextroll, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
1.95%
|
|
|
|
1.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
1.95%
|
|
|
|
1.95%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Skyword, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.00%
|
|
|
|
4.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.00%
|
|
|
|
4.00%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Thumbtack, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured | Exit Fee | Worldremit Group Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche A [Member] | Tectura Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
|
5.00%
|
[7] |
5.00%
|
[11],[25],[37] |
5.00%
|
[7] |
5.00%
|
[11],[25],[37] |
|
|
|
Principal Amount |
|
$ 10,680,000
|
[9],[24],[38] |
$ 10,680,000
|
[20],[25],[37] |
|
|
|
|
|
|
|
Investment cost |
|
240,000
|
[1],[9],[24],[38] |
240,000
|
[2],[20],[25],[37] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[9],[24],[38] |
$ 0
|
[20],[25],[37] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche A [Member] | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
|
|
2025-03
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.00%
|
|
|
|
4.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.25%
|
|
|
|
7.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.25%
|
|
|
|
1.25%
|
|
|
|
|
|
|
Principal Amount |
[9],[17] |
$ 5,027,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[17] |
4,959,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[17] |
$ 4,967,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche A [Member] | Exit Fee | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche B [Member] | Tectura Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
|
8.25%
|
[7] |
8.25%
|
[11],[25],[37] |
8.25%
|
[7] |
8.25%
|
[11],[25],[37] |
|
|
|
Principal Amount |
|
$ 8,250,000
|
[24] |
$ 8,250,000
|
[25],[37] |
|
|
|
|
|
|
|
Investment cost |
|
8,250,000
|
[1],[24] |
8,250,000
|
[2],[25],[37] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,250,000
|
[24] |
$ 8,250,000
|
[25],[37] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche B [Member] | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
|
|
2025-03
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.70%
|
|
|
|
4.70%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.95%
|
|
|
|
7.95%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.50%
|
|
|
|
1.50%
|
|
|
|
|
|
|
Principal Amount |
|
$ 5,014,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
4,932,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 5,055,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche B [Member] | Exit Fee | Veem, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Internet Consumer And Business Services | Senior Secured Tranche C [Member] | Tectura Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
|
5.00%
|
[7] |
5.00%
|
[11],[25],[37] |
5.00%
|
[7] |
5.00%
|
[11],[25],[37] |
|
|
|
Principal Amount |
|
$ 13,023,000
|
[9],[24],[38] |
$ 13,023,000
|
[20],[25],[37] |
|
|
|
|
|
|
|
Investment cost |
|
13,023,000
|
[1],[9],[24],[38] |
13,023,000
|
[2],[20],[25],[37] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
68,000
|
[9],[24],[38] |
19,000
|
[20],[25],[37] |
|
|
|
|
|
|
|
Internet Consumer And Business Services | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
487,830,000
|
[1] |
363,165,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
468,792,000
|
|
$ 349,963,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Convertible Debt | Salary.com, LLC | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13] |
$ 18,000
|
|
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Convertible Debt | Houzz, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2028-05
|
|
|
|
2028-05
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11],[26] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Principal Amount |
[20],[26] |
|
|
$ 20,676,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[20],[26] |
|
|
20,676,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[20],[26] |
|
|
20,425,000
|
|
|
|
|
|
|
|
|
Internet Consumer And Business Services | Convertible Debt | Houzz, Inc. | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-05
|
|
|
|
2028-05
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Principal Amount |
[9],[39] |
$ 21,252,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[39] |
21,252,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[39] |
20,354,000
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
726,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
4,338,000
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
15,902,000
|
[1] |
14,995,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
16,045,000
|
|
$ 14,995,000
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
23,597,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
23,509,000
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Bright Machines, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
151,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 320,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
196,335
|
|
|
|
196,335
|
|
|
|
|
|
|
Manufacturing Technology | MacroFab, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 528,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 603,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
1,111,111
|
|
|
|
1,111,111
|
|
|
|
|
|
|
Manufacturing Technology | Xometry, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
$ 47,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 3,415,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 09, 2018
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
87,784
|
|
|
|
87,784
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | Bright Machines, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2022-11
|
|
2022-11
|
|
2022-11
|
|
2022-11
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[11] |
5.70%
|
[7] |
5.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.95%
|
[7] |
8.95%
|
[11] |
8.95%
|
[7] |
8.95%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
6.95%
|
|
|
|
6.95%
|
|
|
|
|
Principal Amount |
|
$ 15,000,000
|
[8],[12] |
$ 15,000,000
|
[23] |
|
|
|
|
|
|
|
Investment cost |
|
15,902,000
|
[1],[8],[12] |
14,995,000
|
[2],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 16,045,000
|
[8],[12] |
14,995,000
|
[23] |
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | MacroFab, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
|
|
2026-03
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.60%
|
|
|
|
7.60%
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.35%
|
|
|
|
4.35%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.25%
|
|
|
|
1.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.60%
|
|
|
|
7.60%
|
|
|
|
|
|
|
Principal Amount |
[9],[18] |
$ 17,083,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[18] |
16,616,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[18] |
$ 16,469,000
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | Ouster, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
|
|
2026-05
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
6.15%
|
|
|
|
6.15%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.40%
|
|
|
|
9.40%
|
|
|
|
|
|
|
Principal Amount |
[10],[17],[29] |
$ 7,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[17],[29] |
6,981,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[29] |
$ 7,040,000
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | Exit Fee | Bright Machines, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | Exit Fee | MacroFab, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Manufacturing Technology | Senior Secured | Exit Fee | Ouster, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
7.45%
|
|
|
|
7.45%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.45%
|
|
|
|
7.45%
|
|
|
|
|
|
|
Manufacturing Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39,499,000
|
[1] |
14,995,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
39,554,000
|
|
14,995,000
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
17,421,000
|
|
12,612,000
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,953,000
|
[1] |
3,991,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
2,143,000
|
|
10,538,000
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,035,000
|
[1] |
2,483,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
443,000
|
|
2,074,000
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
14,927,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
14,835,000
|
|
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment | Lucira Health, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5] |
110,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Feb. 04, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5] |
59,642
|
|
|
|
59,642
|
|
|
|
|
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250,000
|
[1] |
250,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 400,000
|
|
$ 565,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
|
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250,000
|
[1],[24] |
$ 250,000
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 391,000
|
[24] |
$ 500,000
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 15, 2021
|
[5] |
Oct. 15, 2021
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
5,000,000
|
[24] |
5,000,000
|
[25] |
5,000,000
|
[24] |
5,000,000
|
[25] |
|
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[1],[24] |
$ 0
|
[2],[25] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 9,000
|
[24] |
$ 65,000
|
[25] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 15, 2021
|
[5] |
Oct. 15, 2021
|
[6],[25] |
|
|
|
|
|
|
|
Shares | shares |
|
180,000
|
[24] |
180,000
|
[25] |
180,000
|
[24] |
180,000
|
[25] |
|
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated | Equity | Preferred Series AA |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500,000
|
[1] |
$ 1,500,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 03, 2014
|
[5] |
Nov. 03, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
221,893
|
|
221,893
|
|
221,893
|
|
221,893
|
|
|
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 714,000
|
[1] |
$ 714,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Shares | shares |
|
836,752
|
|
881,131
|
|
836,752
|
|
881,131
|
|
|
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated | Warrant Investment | Preferred Series BB |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 352,000
|
[1] |
$ 351,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 21, 2018
|
[5] |
Sep. 21, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
725,806
|
|
725,806
|
|
725,806
|
|
725,806
|
|
|
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated | Warrant Investment | Preferred Series AA |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 362,000
|
[1],[18] |
$ 363,000
|
[2],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[18] |
$ 0
|
[33] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 03, 2014
|
[5] |
Nov. 03, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
110,946
|
[18] |
155,325
|
[33] |
110,946
|
[18] |
155,325
|
[33] |
|
|
|
Medical Devices & Equipment | Gelesis, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 1,003,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 9,772,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
662,071
|
|
|
|
662,071
|
|
|
|
|
Medical Devices & Equipment | Gelesis, Inc. | Equity | Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 503,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 3,593,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Dec. 30, 2011
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
243,432
|
|
|
|
243,432
|
|
|
|
|
Medical Devices & Equipment | Gelesis, Inc. | Equity | Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 2,828,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Dec. 31, 2011
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
191,626
|
|
|
|
191,626
|
|
|
|
|
Medical Devices & Equipment | Gelesis, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 871,000
|
[1],[5] |
$ 0
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,611,000
|
[5] |
$ 3,351,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 30, 2009
|
[5] |
Nov. 30, 2009
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,490,700
|
[5] |
227,013
|
|
1,490,700
|
[5] |
227,013
|
|
|
|
|
Medical Devices & Equipment | ViewRay, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 332,000
|
[1],[5] |
$ 333,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 132,000
|
[5] |
$ 201,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 16, 2013
|
[5] |
Dec. 16, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
36,457
|
[5] |
36,457
|
[6] |
36,457
|
[5] |
36,457
|
[6] |
|
|
|
Medical Devices & Equipment | Aspire Bariatrics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 455,000
|
[1] |
$ 455,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 28, 2015
|
[5] |
Jan. 28, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
22,572
|
|
22,572
|
|
22,572
|
|
22,572
|
|
|
|
|
Medical Devices & Equipment | Intuity Medical, Inc. | Warrant Investment | Preferred Series B-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 294,000
|
[1] |
$ 294,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 30,000
|
|
$ 264,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 29, 2017
|
[5] |
Dec. 29, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
|
|
|
Medical Devices & Equipment | Outset Medical, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 401,000
|
[1],[5] |
$ 401,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 413,000
|
[5] |
$ 1,797,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 27, 2013
|
[5] |
Sep. 27, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
62,794
|
[5] |
62,794
|
[6] |
62,794
|
[5] |
62,794
|
[6] |
|
|
|
Medical Devices & Equipment | Tela Bio, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61,000
|
[1],[5] |
$ 61,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[5] |
$ 13,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 31, 2017
|
[5] |
Mar. 31, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
15,712
|
[5] |
15,712
|
[6] |
15,712
|
[5] |
15,712
|
[6] |
|
|
|
Medical Devices & Equipment | Medrobotics Corporation | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 905,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
374,703
|
|
|
|
374,703
|
|
|
|
|
Medical Devices & Equipment | Medrobotics Corporation | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Sep. 12, 2013
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
136,798
|
|
|
|
136,798
|
|
|
|
|
Medical Devices & Equipment | Medrobotics Corporation | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 155,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Oct. 22, 2014
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
73,971
|
|
|
|
73,971
|
|
|
|
|
Medical Devices & Equipment | Medrobotics Corporation | Equity | Preferred Series G |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Oct. 16, 2015
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
163,934
|
|
|
|
163,934
|
|
|
|
|
Medical Devices & Equipment | Medrobotics Corporation | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 370,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Mar. 13, 2013
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
455,539
|
|
|
|
455,539
|
|
|
|
|
Medical Devices & Equipment | SonaCare Medical, LLC | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 188,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Sep. 28, 2012
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
6,464
|
|
|
|
6,464
|
|
|
|
|
Medical Devices & Equipment | Senior Secured | Lucira Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-02
|
|
|
|
2026-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Principal Amount |
[17] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[17] |
14,927,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[17] |
$ 14,835,000
|
|
|
|
|
|
|
|
|
|
|
Medical Devices & Equipment | Senior Secured | Exit Fee | Lucira Health, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.25%
|
|
|
|
5.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.25%
|
|
|
|
5.25%
|
|
|
|
|
|
|
Medical Devices & Equipment | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 14,927,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
14,835,000
|
|
|
|
|
|
|
|
|
|
|
Semiconductors |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
20,621,000
|
|
$ 22,498,000
|
|
|
|
|
|
|
|
|
Semiconductors | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
160,000
|
[1] |
160,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
259,000
|
|
725,000
|
|
|
|
|
|
|
|
|
Semiconductors | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
850,000
|
[1] |
850,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
715,000
|
|
2,701,000
|
|
|
|
|
|
|
|
|
Semiconductors | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
19,492,000
|
[1] |
19,072,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
19,647,000
|
|
19,072,000
|
|
|
|
|
|
|
|
|
Semiconductors | Fungible, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
751,000
|
[1],[31] |
751,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 77,000
|
[31] |
$ 751,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 16, 2021
|
[5] |
Dec. 16, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
800,000
|
[31] |
800,000
|
[32] |
800,000
|
[31] |
800,000
|
[32] |
|
|
|
Semiconductors | Achronix Semiconductor Corporation | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 160,000
|
[1] |
$ 160,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 259,000
|
|
$ 725,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 01, 2011
|
[5] |
Jul. 01, 2011
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
277,995
|
|
277,995
|
|
277,995
|
|
277,995
|
|
|
|
|
Semiconductors | Achronix Semiconductor Corporation | Warrant Investment | Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 99,000
|
[1] |
$ 99,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 638,000
|
|
$ 1,950,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 26, 2015
|
[5] |
Jun. 26, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
750,000
|
|
750,000
|
|
750,000
|
|
750,000
|
|
|
|
|
Semiconductors | Senior Secured | Fungible, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[11] |
5.00%
|
[7] |
5.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.25%
|
[7] |
8.25%
|
[11] |
8.25%
|
[7] |
8.25%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Principal Amount |
|
$ 20,000,000
|
[8],[31] |
$ 20,000,000
|
[23],[32] |
|
|
|
|
|
|
|
Investment cost |
|
19,492,000
|
[1],[8],[31] |
19,072,000
|
[2],[23],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 19,647,000
|
[8],[31] |
19,072,000
|
[23],[32] |
|
|
|
|
|
|
|
Semiconductors | Senior Secured | Exit Fee | Fungible, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Semiconductors | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
19,072,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 19,647,000
|
|
19,072,000
|
|
|
|
|
|
|
|
|
Software |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
680,216,000
|
|
585,622,000
|
|
|
|
|
|
|
|
|
Software | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
24,006,000
|
[1] |
23,905,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
24,997,000
|
|
45,087,000
|
|
|
|
|
|
|
|
|
Software | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
7,639,000
|
[1] |
5,594,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
6,217,000
|
|
11,133,000
|
|
|
|
|
|
|
|
|
Software | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
381,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
381,000
|
|
|
|
|
|
|
|
|
|
|
Software | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
10,691,000
|
[1] |
68,743,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
10,691,000
|
|
68,287,000
|
|
|
|
|
|
|
|
|
Software | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
614,819,000
|
[1] |
437,659,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
615,863,000
|
|
441,115,000
|
|
|
|
|
|
|
|
|
Software | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
22,066,000
|
[1] |
19,851,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
22,066,000
|
|
20,000,000
|
|
|
|
|
|
|
|
|
Software | Automation Anywhere, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
448,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 437,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
254,778
|
|
|
|
254,778
|
|
|
|
|
|
|
Software | Cutover, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[29],[30] |
102,898
|
|
|
|
102,898
|
|
|
|
|
|
|
Software | Liberty Zim Co-Invest L.P. | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
$ 381,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 381,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jul. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
Software | Delphix Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,594,000
|
[1] |
1,594,000
|
[2],[21] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,306,000
|
|
$ 3,275,000
|
[21] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 08, 2019
|
[5] |
Oct. 08, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
718,898
|
|
718,898
|
[21] |
718,898
|
|
718,898
|
[21] |
|
|
|
Software | Pymetrics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 77,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 218,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Sep. 15, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
150,943
|
|
|
|
150,943
|
|
|
|
|
Software | 3GTMS, LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1] |
$ 1,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 675,000
|
|
$ 985,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 09, 2021
|
[5] |
Aug. 09, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
|
|
|
Software | Brain Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 165,000
|
[1],[31] |
$ 165,000
|
[2],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 61,000
|
[31] |
$ 132,000
|
[32] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 04, 2021
|
[5] |
Oct. 04, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
194,629
|
[31] |
194,629
|
[32] |
194,629
|
[31] |
194,629
|
[32] |
|
|
|
Software | CloudBolt Software, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 117,000
|
[1] |
$ 117,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,000
|
|
$ 85,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 30, 2020
|
[5] |
Sep. 30, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
211,342
|
|
211,342
|
|
211,342
|
|
211,342
|
|
|
|
|
Software | Dashlane, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 353,000
|
[1] |
$ 404,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 120,000
|
|
$ 415,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 11, 2019
|
[5] |
Mar. 11, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
453,641
|
|
560,536
|
|
453,641
|
|
560,536
|
|
|
|
|
Software | Demandbase, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 545,000
|
[1] |
$ 404,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 140,000
|
|
$ 443,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 02, 2021
|
[5] |
Aug. 02, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
727,047
|
|
483,248
|
|
727,047
|
|
483,248
|
|
|
|
|
Software | Eigen Technologies Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
$ 8,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 8,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 13, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[29],[30] |
522
|
|
|
|
522
|
|
|
|
|
|
|
Software | Esme Learning Solutions, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 198,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jan. 27, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
56,765
|
|
|
|
56,765
|
|
|
|
|
|
|
Software | Mixpanel, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 252,000
|
[1] |
$ 252,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 233,000
|
|
$ 906,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 30, 2020
|
[5] |
Sep. 30, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
82,362
|
|
82,362
|
|
82,362
|
|
82,362
|
|
|
|
|
Software | Nuvolo Technologies Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 172,000
|
[1] |
$ 88,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 190,000
|
|
$ 283,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 29, 2019
|
[5] |
Mar. 29, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
70,000
|
|
50,000
|
|
70,000
|
|
50,000
|
|
|
|
|
Software | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
|
$ 20,498,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 21,030,000
|
[1] |
20,533,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
22,014,000
|
|
20,406,000
|
|
|
|
|
|
|
|
|
Software | Tact.ai Technologies, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
206,000
|
[1] |
206,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 90,000
|
|
$ 162,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 13, 2020
|
[5] |
Feb. 13, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,041,667
|
|
1,041,667
|
|
1,041,667
|
|
1,041,667
|
|
|
|
|
Software | Udacity, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 218,000
|
[1] |
$ 218,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,000
|
|
$ 345,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 25, 2020
|
[5] |
Sep. 25, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
486,359
|
|
486,359
|
|
486,359
|
|
486,359
|
|
|
|
|
Software | VideoAmp, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[31] |
$ 1,275,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[31] |
$ 416,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jan. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[31] |
152,048
|
|
|
|
152,048
|
|
|
|
|
|
|
Software | Zimperium, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 72,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 56,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jul. 02, 2021
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
20,563
|
|
|
|
20,563
|
|
|
|
|
Software | SingleStore, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,280,000
|
[1] |
$ 2,279,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,428,000
|
|
$ 2,479,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
633,939
|
|
633,939
|
|
633,939
|
|
633,939
|
|
|
|
|
Software | SingleStore, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000,000
|
[1] |
$ 2,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,278,000
|
|
$ 2,239,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 25, 2020
|
[5] |
Nov. 25, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
580,983
|
|
580,983
|
|
580,983
|
|
580,983
|
|
|
|
|
Software | SingleStore, Inc. | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 280,000
|
[1] |
$ 279,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 150,000
|
|
$ 240,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 12, 2021
|
[5] |
Aug. 12, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
52,956
|
|
52,956
|
|
52,956
|
|
52,956
|
|
|
|
|
Software | SingleStore, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 103,000
|
[1] |
$ 103,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 258,000
|
|
$ 704,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 28, 2020
|
[5] |
Apr. 28, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
312,596
|
|
312,596
|
|
312,596
|
|
312,596
|
|
|
|
|
Software | CapLinked, Inc. | Equity | Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 51,000
|
[1] |
$ 51,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 5,000
|
|
$ 65,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 26, 2012
|
[5] |
Oct. 26, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
53,614
|
|
53,614
|
|
53,614
|
|
53,614
|
|
|
|
|
Software | Docker, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,284,000
|
[1] |
$ 4,284,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 494,000
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 29, 2018
|
[5] |
Nov. 29, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
20,000
|
|
20,000
|
|
20,000
|
|
20,000
|
|
|
|
|
Software | Druva Holdings, Inc. | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,300,000
|
[1] |
$ 1,300,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,758,000
|
|
$ 2,916,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
552,461
|
|
552,461
|
|
552,461
|
|
552,461
|
|
|
|
|
Software | Druva Holdings, Inc. | Equity | Preferred Series 3 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 300,000
|
[1] |
$ 300,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 330,000
|
|
$ 529,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 24, 2017
|
[5] |
Aug. 24, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
93,620
|
|
93,620
|
|
93,620
|
|
93,620
|
|
|
|
|
Software | Druva Holdings, Inc. | Equity | Preferred Series 2 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000,000
|
[1] |
$ 1,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,428,000
|
|
$ 2,387,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Oct. 22, 2015
|
[5] |
Oct. 22, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
458,841
|
|
458,841
|
|
458,841
|
|
458,841
|
|
|
|
|
Software | HighRoads, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 307,000
|
[1] |
$ 307,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 18, 2013
|
[5] |
Jan. 18, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
190
|
|
190
|
|
190
|
|
190
|
|
|
|
|
Software | Lightbend, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 265,000
|
[1] |
$ 265,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 14,000
|
|
$ 5,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 04, 2020
|
[5] |
Dec. 04, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
38,461
|
|
38,461
|
|
38,461
|
|
38,461
|
|
|
|
|
Software | Lightbend, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 131,000
|
[1] |
$ 131,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,000
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Feb. 14, 2018
|
[5] |
Feb. 14, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
89,685
|
|
89,685
|
|
89,685
|
|
89,685
|
|
|
|
|
Software | Palantir Technologies | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 8,670,000
|
[1],[5] |
$ 8,670,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 11,531,000
|
[5] |
$ 25,828,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 23, 2020
|
[5] |
Sep. 23, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,418,337
|
[5] |
1,418,337
|
[6] |
1,418,337
|
[5] |
1,418,337
|
[6] |
|
|
|
Software | Sprinklr, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,748,000
|
[1],[5] |
$ 3,749,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 6,454,000
|
[5] |
$ 11,109,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 22, 2017
|
[5] |
Mar. 22, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
700,000
|
[5] |
700,000
|
[6] |
700,000
|
[5] |
700,000
|
[6] |
|
|
|
Software | Verana Health, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000,000
|
[1] |
$ 2,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,171,000
|
|
$ 1,697,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jul. 08, 2021
|
[5] |
Jul. 08, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
952,562
|
|
952,562
|
|
952,562
|
|
952,562
|
|
|
|
|
Software | Bitsight Technologies Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 284,000
|
[1] |
$ 284,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 597,000
|
|
$ 1,272,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 18, 2020
|
[5] |
Nov. 18, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
29,691
|
|
29,691
|
|
29,691
|
|
29,691
|
|
|
|
|
Software | Cloudian Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 71,000
|
[1] |
$ 71,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 17,000
|
|
$ 33,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 06, 2018
|
[5] |
Nov. 06, 2018
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
477,454
|
|
477,454
|
|
477,454
|
|
477,454
|
|
|
|
|
Software | Dronedeploy Incorporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 278,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 307,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 30, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
95,911
|
|
|
|
95,911
|
|
|
|
|
|
|
Software | Evernote Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 107,000
|
[1] |
$ 106,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 15,000
|
|
$ 65,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Sep. 30, 2016
|
[5] |
Sep. 30, 2016
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
62,500
|
|
62,500
|
|
62,500
|
|
62,500
|
|
|
|
|
Software | Poplicus Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[1] |
$ 0
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 28, 2014
|
[5] |
May 28, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
132,168
|
|
132,168
|
|
132,168
|
|
132,168
|
|
|
|
|
Software | Reltio Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 215,000
|
[1] |
$ 215,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 296,000
|
|
$ 637,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 30, 2020
|
[5] |
Jun. 30, 2020
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
69,120
|
|
69,120
|
|
69,120
|
|
69,120
|
|
|
|
|
Software | Sign Post Inc | Warrant Investment | Series Junior 1 Preferred |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 314,000
|
[1] |
$ 314,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jan. 13, 2016
|
[5] |
Jan. 13, 2016
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
474,019
|
|
474,019
|
|
474,019
|
|
474,019
|
|
|
|
|
Software | Zero Fox Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[22] |
$ 101,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[22] |
$ 1,467,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
May 07, 2020
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[22] |
289,992
|
|
|
|
289,992
|
|
|
|
|
|
|
Software | Zero Fox Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 101,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 603,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
May 07, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
648,350
|
|
|
|
648,350
|
|
|
|
|
Software | Couchbase Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 462,000
|
[1],[5] |
$ 462,000
|
[2],[6],[34] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 563,000
|
[5] |
$ 1,343,000
|
[6],[34] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 25, 2019
|
[5] |
Apr. 25, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
105,350
|
[5] |
105,350
|
[6],[34] |
105,350
|
[5] |
105,350
|
[6],[34] |
|
|
|
Software | D N Anexus Inc | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 97,000
|
[1] |
$ 97,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 114,000
|
|
$ 102,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 21, 2014
|
[5] |
Mar. 21, 2014
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
909,091
|
|
909,091
|
|
909,091
|
|
909,091
|
|
|
|
|
Software | Fuze, Inc. | Warrant Investment | Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 89,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jun. 30, 2017
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
256,158
|
|
|
|
256,158
|
|
|
|
|
Software | Rapid Miner Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 24,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 54,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Nov. 28, 2017
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
4,982
|
|
|
|
4,982
|
|
|
|
|
Software | Senior Secured | Automation Anywhere, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
|
|
2027-09
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.25%
|
|
|
|
4.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.00%
|
|
|
|
9.00%
|
|
|
|
|
|
|
Principal Amount |
[8],[10] |
$ 19,600,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8],[10] |
19,008,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[10] |
$ 19,008,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Constructor.io Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.44%
|
|
|
|
8.44%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.44%
|
|
|
|
9.44%
|
|
|
|
|
|
|
Principal Amount |
[10],[13] |
$ 4,688,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[13] |
4,569,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[13] |
$ 4,569,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Omeda Holdings, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.05%
|
|
|
|
8.05%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.05%
|
|
|
|
9.05%
|
|
|
|
|
|
|
Principal Amount |
[10],[13] |
$ 7,500,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[13] |
7,251,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[13] |
$ 7,251,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Cutover, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-10
|
|
|
|
2025-10
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.20%
|
|
|
|
5.20%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
9.95%
|
|
|
|
9.95%
|
|
|
|
|
|
|
Principal Amount |
[29],[30] |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
4,927,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 4,927,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Delphix Corp. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-02
|
|
|
|
2023-02
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
5.00%
|
|
|
|
5.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
10.25%
|
|
|
|
10.25%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
5.00%
|
|
|
|
5.00%
|
|
|
|
|
Principal Amount |
[21],[23],[33] |
|
|
$ 60,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[23],[33] |
|
|
61,736,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[21],[23],[33] |
|
|
$ 62,345,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Khoros (p.k.a Lithium Technologies) | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-10
|
|
|
|
2022-10
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
8.00%
|
|
|
|
8.00%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
9.00%
|
|
|
|
9.00%
|
|
|
|
|
Principal Amount |
[15] |
|
|
$ 56,208,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[15] |
|
|
55,834,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[15] |
|
|
$ 55,834,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Khoros (p.k.a Lithium Technologies) | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-01
|
|
|
|
2024-01
|
|
|
|
|
|
|
Principal Amount |
[10] |
$ 56,208,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10] |
56,028,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10] |
$ 55,958,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Pymetrics, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-10
|
|
|
|
2022-10
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.75%
|
|
|
|
8.75%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11] |
|
|
1.75%
|
|
|
|
1.75%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.00%
|
|
|
|
4.00%
|
|
|
|
|
Principal Amount |
[20] |
|
|
$ 9,667,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[20] |
|
|
9,845,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[20] |
|
|
$ 9,845,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | 3GTMS, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.28%
|
[7] |
9.28%
|
[11] |
9.28%
|
[7] |
9.28%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.28%
|
[7] |
10.28%
|
[11] |
10.28%
|
[7] |
10.28%
|
[11] |
|
|
|
Principal Amount |
|
$ 10,808,000
|
[10],[12],[13] |
$ 10,000,000
|
[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
10,660,000
|
[1],[10],[12],[13] |
9,812,000
|
[2],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 10,496,000
|
[10],[12],[13] |
$ 9,656,000
|
[15],[16] |
|
|
|
|
|
|
|
Software | Senior Secured | Agilence, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[11] |
9.00%
|
[7] |
9.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.00%
|
[7] |
10.00%
|
[11] |
10.00%
|
[7] |
10.00%
|
[11] |
|
|
|
Principal Amount |
|
$ 9,330,000
|
[10],[13],[18] |
$ 9,400,000
|
[15] |
|
|
|
|
|
|
|
Investment cost |
|
9,100,000
|
[1],[10],[13],[18] |
9,138,000
|
[2],[15] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,880,000
|
[10],[13],[18] |
$ 9,138,000
|
[15] |
|
|
|
|
|
|
|
Software | Senior Secured | Annex Cloud | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-02
|
|
|
|
2027-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
9.00%
|
|
|
|
9.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
10.00%
|
|
|
|
10.00%
|
|
|
|
|
|
|
Principal Amount |
[10],[17] |
$ 8,500,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[17] |
8,282,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[17] |
$ 8,148,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Brain Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.70%
|
[7] |
3.70%
|
[11] |
3.70%
|
[7] |
3.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
6.95%
|
[7] |
6.95%
|
[11] |
6.95%
|
[7] |
6.95%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.00%
|
[7] |
1.00%
|
[11] |
1.00%
|
[7] |
1.00%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Principal Amount |
|
$ 20,116,000
|
[9],[10],[17],[31] |
$ 10,016,000
|
[15],[20],[32] |
|
|
|
|
|
|
|
Investment cost |
|
20,101,000
|
[1],[9],[10],[17],[31] |
9,943,000
|
[2],[15],[20],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 20,196,000
|
[9],[10],[17],[31] |
$ 9,943,000
|
[15],[20],[32] |
|
|
|
|
|
|
|
Software | Senior Secured | Campaign Monitor Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-11
|
|
2025-11
|
|
2025-11
|
|
2025-11
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
8.90%
|
[7] |
7.90%
|
[11] |
8.90%
|
[7] |
7.90%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.90%
|
[7] |
11.15%
|
[11] |
9.90%
|
[7] |
11.15%
|
[11] |
|
|
|
Principal Amount |
|
$ 33,000,000
|
[8],[17] |
$ 33,000,000
|
[23] |
|
|
|
|
|
|
|
Investment cost |
|
32,546,000
|
[1],[8],[17] |
32,459,000
|
[2],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 32,944,000
|
[8],[17] |
$ 33,000,000
|
[23] |
|
|
|
|
|
|
|
Software | Senior Secured | Catchpoint Systems, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
|
|
2026-06
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.76%
|
|
|
|
8.76%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7],[10],[13] |
9.76%
|
|
|
|
9.76%
|
|
|
|
|
|
|
Principal Amount |
[13] |
$ 10,200,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[13] |
10,034,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13] |
$ 10,043,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Ceros, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
8.89%
|
[7] |
8.89%
|
[11] |
8.89%
|
[7] |
8.89%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.89%
|
[7],[10],[13] |
9.89%
|
[11] |
9.89%
|
[7],[10],[13] |
9.89%
|
[11] |
|
|
|
Principal Amount |
|
$ 19,855,000
|
[10],[13] |
$ 17,978,000
|
[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
19,420,000
|
[1],[10],[13] |
17,474,000
|
[2],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 19,482,000
|
[10],[13] |
$ 17,474,000
|
[15],[16] |
|
|
|
|
|
|
|
Software | Senior Secured | CloudBolt Software, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
2.95%
|
|
|
|
2.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.70%
|
[7] |
6.70%
|
[11] |
6.70%
|
[7] |
6.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.95%
|
[7] |
9.95%
|
[11] |
9.95%
|
[7] |
9.95%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
2.95%
|
|
|
|
2.95%
|
|
|
|
|
Principal Amount |
|
$ 10,000,000
|
[8],[12],[18] |
$ 10,000,000
|
[14],[23],[33] |
|
|
|
|
|
|
|
Investment cost |
|
10,021,000
|
[1],[8],[12],[18] |
9,923,000
|
[2],[14],[23],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 10,014,000
|
[8],[12],[18] |
$ 10,035,000
|
[14],[23],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Copper CRM, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
|
|
2025-03
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.25%
|
|
|
|
8.25%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.95%
|
|
|
|
1.95%
|
|
|
|
|
|
|
Principal Amount |
[9],[12] |
$ 10,095,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[12] |
10,058,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[12] |
$ 9,882,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Cybermaxx Intermediate Holdings, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
|
2026-08
|
|
2026-08
|
|
2026-08
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.28%
|
[7] |
9.28%
|
[11] |
9.28%
|
[7] |
9.28%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.28%
|
[7] |
10.28%
|
[11] |
10.28%
|
[7] |
10.28%
|
[11] |
|
|
|
Principal Amount |
|
$ 7,980,000
|
[10],[17] |
$ 8,000,000
|
[15] |
|
|
|
|
|
|
|
Investment cost |
|
7,808,000
|
[1],[10],[17] |
7,801,000
|
[2],[15] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 7,732,000
|
[10],[17] |
$ 7,801,000
|
[15] |
|
|
|
|
|
|
|
Software | Senior Secured | Dashlane, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
7.10%
|
|
|
|
7.10%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
3.05%
|
[7] |
3.05%
|
[11] |
3.05%
|
[7] |
3.05%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
7.55%
|
[7] |
7.55%
|
[11] |
7.55%
|
[7] |
7.55%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.10%
|
[7] |
1.10%
|
[11] |
1.10%
|
[7] |
1.10%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
7.10%
|
|
|
|
7.10%
|
|
|
|
|
Principal Amount |
|
$ 31,841,000
|
[8],[9],[10],[12],[17] |
$ 20,719,000
|
[14],[15],[20],[23] |
|
|
|
|
|
|
|
Investment cost |
|
32,186,000
|
[1],[8],[9],[10],[12],[17] |
21,807,000
|
[2],[14],[15],[20],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 31,580,000
|
[8],[9],[10],[12],[17] |
$ 21,734,000
|
[14],[15],[20],[23] |
|
|
|
|
|
|
|
Software | Senior Secured | Demandbase, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
2.25%
|
[7] |
5.25%
|
[11] |
2.25%
|
[7] |
5.25%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
5.50%
|
[7] |
8.50%
|
[11] |
5.50%
|
[7] |
8.50%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Principal Amount |
|
$ 28,288,000
|
[8],[9],[10],[17] |
$ 16,875,000
|
[15],[23] |
|
|
|
|
|
|
|
Investment cost |
|
28,010,000
|
[1],[8],[9],[10],[17] |
16,463,000
|
[2],[15],[23] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 28,187,000
|
[8],[9],[10],[17] |
$ 16,463,000
|
[15],[23] |
|
|
|
|
|
|
|
Software | Senior Secured | Eigen Technologies Ltd. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
|
|
2025-04
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.10%
|
|
|
|
5.10%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.35%
|
|
|
|
8.35%
|
|
|
|
|
|
|
Principal Amount |
[29],[30] |
$ 3,750,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29],[30] |
3,730,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[29],[30] |
$ 3,726,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Enmark Systems, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
6.83%
|
[7] |
6.83%
|
[11] |
6.83%
|
[7] |
6.83%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
7.83%
|
[7] |
7.83%
|
[11] |
7.83%
|
[7] |
7.83%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
2.19%
|
[7] |
2.19%
|
[11] |
2.19%
|
[7] |
2.19%
|
[11] |
|
|
|
Principal Amount |
|
$ 8,178,000
|
[9],[10],[12],[13] |
$ 8,000,000
|
[14],[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
8,001,000
|
[1],[9],[10],[12],[13] |
7,798,000
|
[2],[14],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 7,948,000
|
[9],[10],[12],[13] |
$ 7,798,000
|
[14],[15],[16] |
|
|
|
|
|
|
|
Software | Senior Secured | Esentire, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.96%
|
[7] |
9.96%
|
[11],[27],[28] |
9.96%
|
[7] |
9.96%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
|
10.96%
|
[7] |
10.96%
|
[11],[27],[28] |
10.96%
|
[7] |
10.96%
|
[11],[27],[28] |
|
|
|
Principal Amount |
|
$ 8,468,000
|
[12],[13],[29],[30] |
$ 21,000,000
|
[14],[16],[27],[28] |
|
|
|
|
|
|
|
Investment cost |
|
8,380,000
|
[1],[12],[13],[29],[30] |
20,699,000
|
[2],[14],[16],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 8,425,000
|
[12],[13],[29],[30] |
$ 20,750,000
|
[14],[16],[27],[28] |
|
|
|
|
|
|
|
Software | Senior Secured | Esme Learning Solutions, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
|
|
2025-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.50%
|
|
|
|
1.50%
|
|
|
|
|
|
|
Principal Amount |
[9] |
$ 5,045,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9] |
4,890,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9] |
$ 4,270,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Gryphon Networks Corp. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.69%
|
[7] |
9.69%
|
[11] |
9.69%
|
[7] |
9.69%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.69%
|
[7] |
10.69%
|
[11] |
10.69%
|
[7] |
10.69%
|
[11] |
|
|
|
Principal Amount |
|
$ 5,232,000
|
[10],[12] |
$ 5,232,000
|
[14],[15] |
|
|
|
|
|
|
|
Investment cost |
|
5,125,000
|
[1],[10],[12] |
5,106,000
|
[2],[14],[15] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 5,258,000
|
[10],[12] |
$ 5,088,000
|
[14],[15] |
|
|
|
|
|
|
|
Software | Senior Secured | Ikon Science Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[11],[27],[28] |
9.00%
|
[7] |
9.00%
|
[11],[27],[28] |
|
|
|
Investment, Interest Rate, Floor |
[7] |
10.00%
|
|
|
|
10.00%
|
|
|
|
|
|
|
Principal Amount |
|
$ 6,650,000
|
[10],[13],[29],[30] |
$ 6,913,000
|
[15],[16],[27],[28] |
|
|
|
|
|
|
|
Investment cost |
|
6,510,000
|
[1],[10],[13],[29],[30] |
6,719,000
|
[2],[15],[16],[27],[28] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 6,572,000
|
[10],[13],[29],[30] |
$ 6,767,000
|
[15],[16],[27],[28] |
|
|
|
|
|
|
|
Software | Senior Secured | Imperva, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
|
|
2027-01
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.75%
|
|
|
|
8.75%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.75%
|
|
|
|
7.75%
|
|
|
|
|
|
|
Principal Amount |
[8] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8] |
19,869,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Imperva, Inc. | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2027-01
|
|
|
|
2027-01
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
7.75%
|
|
|
|
7.75%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.75%
|
|
|
|
8.75%
|
|
|
|
|
Principal Amount |
[23] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23] |
|
|
19,851,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[23] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-07
|
|
|
|
2023-07
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
10.15%
|
|
|
|
10.15%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
11.15%
|
|
|
|
11.15%
|
|
|
|
|
|
|
Principal Amount |
[13] |
$ 10,819,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[13] |
10,691,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13] |
$ 10,691,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-07
|
|
|
|
2023-07
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
8.00%
|
[7] |
10.14%
|
[11] |
8.00%
|
[7] |
10.14%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.00%
|
[7] |
11.14%
|
[11] |
9.00%
|
[7] |
11.14%
|
[11] |
|
|
|
Principal Amount |
[16] |
|
|
$ 8,571,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[16] |
|
|
8,403,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[16] |
|
|
$ 8,375,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Logicworks | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-01
|
|
2024-01
|
|
2024-01
|
|
2024-01
|
|
|
|
|
Investment Interest Rate |
[7] |
0.75%
|
|
|
|
0.75%
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
7.50%
|
[7] |
7.50%
|
[11] |
7.50%
|
[7] |
7.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
10.75%
|
|
|
|
10.75%
|
|
|
|
|
Interest Rate and Floor |
[7] |
0.75%
|
|
|
|
0.75%
|
|
|
|
|
|
|
Principal Amount |
|
$ 14,500,000
|
[18] |
$ 10,000,000
|
[15],[33] |
|
|
|
|
|
|
|
Investment cost |
|
14,373,000
|
[1],[18] |
9,862,000
|
[2],[15],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 14,356,000
|
[18] |
$ 9,965,000
|
[15],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Mixpanel, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.70%
|
[7] |
4.70%
|
[11] |
4.70%
|
[7] |
4.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
7.95%
|
[7] |
7.95%
|
[11] |
7.95%
|
[7] |
7.95%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.80%
|
[7] |
1.80%
|
[11] |
1.80%
|
[7] |
1.80%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Principal Amount |
|
$ 20,713,000
|
[8],[9] |
$ 20,431,000
|
[20],[23],[33] |
|
|
|
|
|
|
|
Investment cost |
|
20,755,000
|
[1],[8],[9] |
20,292,000
|
[2],[20],[23],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,554,000
|
[8],[9] |
$ 21,030,000
|
[20],[23],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Mobile Solutions Services | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.06%
|
[7] |
9.87%
|
[11] |
9.06%
|
[7] |
9.87%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.06%
|
[7] |
10.87%
|
[11] |
10.06%
|
[7] |
10.87%
|
[11] |
|
|
|
Principal Amount |
|
$ 17,668,000
|
[10],[13] |
$ 19,074,000
|
[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
17,283,000
|
[1],[10],[13] |
18,575,000
|
[2],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 16,984,000
|
[10],[13] |
$ 18,834,000
|
[15],[16] |
|
|
|
|
|
|
|
Software | Senior Secured | Nuvolo Technologies Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
1.75%
|
|
|
|
1.75%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.25%
|
[7] |
7.70%
|
[11] |
5.25%
|
[7] |
7.70%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.50%
|
[7] |
10.95%
|
[11] |
8.50%
|
[7] |
10.95%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
1.75%
|
|
|
|
1.75%
|
|
|
|
|
Principal Amount |
|
$ 17,500,000
|
[8],[10],[17],[18] |
$ 15,000,000
|
[23],[33] |
|
|
|
|
|
|
|
Investment cost |
|
17,525,000
|
[1],[8],[10],[17],[18] |
14,967,000
|
[2],[23],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
17,586,000
|
[8],[10],[17],[18] |
$ 15,017,000
|
[23],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 20,662,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Riviera Partners LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-04
|
|
|
|
2027-04
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
7.53%
|
|
|
|
7.53%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.53%
|
|
|
|
8.53%
|
|
|
|
|
|
|
Principal Amount |
[10],[13] |
$ 26,184,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[13] |
25,595,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[13] |
$ 25,595,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | ShadowDragon, LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[11] |
9.00%
|
[7] |
9.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.00%
|
[7] |
10.00%
|
[11] |
10.00%
|
[7] |
10.00%
|
[11] |
|
|
|
Principal Amount |
|
$ 6,000,000
|
[13] |
$ 6,000,000
|
[15],[16] |
|
|
|
|
|
|
|
Investment cost |
|
5,849,000
|
[1],[13] |
5,828,000
|
[2],[15],[16] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 5,780,000
|
[13] |
$ 5,828,000
|
[15],[16] |
|
|
|
|
|
|
|
Software | Senior Secured | Tact.ai Technologies, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-02
|
|
2024-02
|
|
2024-02
|
|
2024-02
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.00%
|
[7] |
4.00%
|
[11] |
4.00%
|
[7] |
4.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.75%
|
[7] |
8.75%
|
[11] |
8.75%
|
[7] |
8.75%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
2.00%
|
[7] |
2.00%
|
[11] |
2.00%
|
[7] |
2.00%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
5.50%
|
|
|
|
5.50%
|
|
|
|
|
Principal Amount |
|
$ 5,009,000
|
[9] |
$ 5,185,000
|
[20] |
|
|
|
|
|
|
|
Investment cost |
|
5,213,000
|
[1],[9] |
5,305,000
|
[2],[20] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 4,885,000
|
[9] |
$ 5,245,000
|
[33] |
|
|
|
|
|
|
|
Software | Senior Secured | ThreatConnect, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2026-05
|
|
2026-05
|
|
2026-05
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[11] |
9.00%
|
[7] |
9.00%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
10.00%
|
[7] |
10.00%
|
[11] |
10.00%
|
[7] |
10.00%
|
[11] |
|
|
|
Principal Amount |
|
$ 11,060,000
|
[10],[13],[18] |
$ 11,144,000
|
[15],[16],[33] |
|
|
|
|
|
|
|
Investment cost |
|
10,791,000
|
[1],[10],[13],[18] |
10,831,000
|
[2],[15],[16],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 10,832,000
|
[10],[13],[18] |
$ 10,859,000
|
[15],[16],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Udacity, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.50%
|
[7] |
4.50%
|
[11] |
4.50%
|
[7] |
4.50%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
7.75%
|
[7] |
7.75%
|
[11] |
7.75%
|
[7] |
7.75%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
2.00%
|
[7] |
2.00%
|
[11] |
2.00%
|
[7] |
2.00%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
3.00%
|
|
|
|
3.00%
|
|
|
|
|
Principal Amount |
|
$ 51,675,000
|
[9],[18] |
$ 50,895,000
|
[20],[33] |
|
|
|
|
|
|
|
Investment cost |
|
51,851,000
|
[1],[9],[18] |
50,646,000
|
[2],[20],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 52,330,000
|
[9],[18] |
$ 51,722,000
|
[20],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | VideoAmp, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
|
|
2025-02
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
3.70%
|
|
|
|
3.70%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
6.95%
|
|
|
|
6.95%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.25%
|
|
|
|
1.25%
|
|
|
|
|
|
|
Principal Amount |
[8],[9],[31] |
$ 62,987,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[8],[9],[31] |
62,056,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[31] |
$ 62,467,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Zimperium, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
|
2024-07
|
|
2027-05
|
|
2024-07
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
8.31%
|
[7] |
8.95%
|
[11] |
8.31%
|
[7] |
8.95%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
9.31%
|
[7] |
9.95%
|
[11] |
9.31%
|
[7] |
9.95%
|
[11] |
|
|
|
Principal Amount |
|
$ 16,313,000
|
[10],[13] |
$ 15,633,000
|
[16],[33] |
|
|
|
|
|
|
|
Investment cost |
|
15,984,000
|
[1],[10],[13] |
15,347,000
|
[2],[16],[33] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 15,984,000
|
[10],[13] |
$ 15,347,000
|
[16],[33] |
|
|
|
|
|
|
|
Software | Senior Secured | Alchemer LLC | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-05
|
|
|
|
2028-05
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
7.89%
|
|
|
|
7.89%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.89%
|
|
|
|
8.89%
|
|
|
|
|
|
|
Principal Amount |
[10],[13] |
$ 15,125,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[13] |
14,778,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[13] |
$ 14,778,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Dispatch Technologies, Inc. | Greater than 5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-04
|
|
|
|
2028-04
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
8.01%
|
|
|
|
8.01%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
8.76%
|
|
|
|
8.76%
|
|
|
|
|
|
|
Principal Amount |
[10],[13] |
$ 7,500,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[10],[13] |
7,288,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[10],[13] |
$ 7,288,000
|
|
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Reltio Inc | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2023-07
|
|
|
|
2023-07
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
5.70%
|
|
|
|
5.70%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.95%
|
|
|
|
8.95%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11] |
|
|
1.70%
|
|
|
|
1.70%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
|
|
|
Principal Amount |
[20],[23] |
|
|
$ 10,248,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[20],[23] |
|
|
10,336,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[20],[23] |
|
|
$ 10,542,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Regent Education | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-01
|
|
|
|
2022-01
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
[11],[37] |
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Investment Interest Rate |
[11],[37] |
|
|
7.94%
|
|
|
|
7.94%
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11],[37] |
|
|
2.00%
|
|
|
|
2.00%
|
|
|
|
|
Interest Rate and Floor |
[11],[37] |
|
|
7.94%
|
|
|
|
7.94%
|
|
|
|
|
Principal Amount |
[20],[37] |
|
|
$ 2,951,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[20],[37] |
|
|
3,064,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[20],[37] |
|
|
$ 2,608,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Cloud 9 Software | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2024-04
|
|
|
|
2024-04
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
8.20%
|
|
|
|
8.20%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
9.20%
|
|
|
|
9.20%
|
|
|
|
|
Principal Amount |
[33] |
|
|
$ 9,953,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
|
|
9,856,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[33] |
|
|
$ 9,953,000
|
|
|
|
|
|
|
|
|
Software | Senior Secured | Floor Rate | Ikon Science Limited | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[11],[27],[28] |
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Software | Senior Secured | Exit Fee | Automation Anywhere, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
2.50%
|
|
|
|
2.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.50%
|
|
|
|
2.50%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Cutover, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Brain Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | CloudBolt Software, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.45%
|
|
|
|
3.45%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.45%
|
|
|
|
3.45%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Copper CRM, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Dashlane, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
|
|
4.95%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Demandbase, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
2.00%
|
|
|
|
2.00%
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.00%
|
|
|
|
5.00%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Eigen Technologies Ltd. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
2.95%
|
|
|
|
2.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.95%
|
|
|
|
2.95%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Esme Learning Solutions, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Mixpanel, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Nuvolo Technologies Corporation | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
2.04%
|
|
|
|
2.04%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.04%
|
|
|
|
2.04%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Tact.ai Technologies, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.50%
|
|
|
|
5.50%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | Udacity, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
|
|
3.00%
|
|
|
|
|
|
|
Software | Senior Secured | Exit Fee | VideoAmp, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
5.25%
|
|
|
|
5.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.25%
|
|
|
|
5.25%
|
|
|
|
|
|
|
Software | Senior Secured | Cap Rate | Copper CRM, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
10.25%
|
|
|
|
10.25%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.25%
|
|
|
|
10.25%
|
|
|
|
|
|
|
Software | Senior Secured Tranche A [Member] | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-11
|
|
2023-11
|
|
2023-11
|
|
2023-11
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.50%
|
|
|
|
4.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
4.75%
|
[7] |
4.75%
|
[11] |
4.75%
|
[7] |
4.75%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.00%
|
[7] |
8.00%
|
[11] |
8.00%
|
[7] |
8.00%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
0.50%
|
[7] |
0.50%
|
[11] |
0.50%
|
[7] |
0.50%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.50%
|
|
|
|
4.50%
|
|
|
|
|
Principal Amount |
|
$ 7,486,000
|
[9] |
$ 7,457,000
|
[20] |
|
|
|
|
|
|
|
Investment cost |
|
7,657,000
|
[1],[9] |
7,528,000
|
[2],[20] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 7,975,000
|
[9] |
$ 7,314,000
|
[20] |
|
|
|
|
|
|
|
Software | Senior Secured Tranche A [Member] | Exit Fee | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Software | Senior Secured Tranche B [Member] | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-11
|
|
2023-11
|
|
2023-11
|
|
2023-11
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
4.50%
|
|
|
|
4.50%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
|
5.25%
|
[7] |
5.25%
|
[11] |
5.25%
|
[7] |
5.25%
|
[11] |
|
|
|
Investment, Interest Rate, Floor |
|
8.50%
|
[7] |
8.50%
|
[11] |
8.50%
|
[7] |
8.50%
|
[11] |
|
|
|
Investment, Interest Rate, Paid in Kind |
|
1.35%
|
[7] |
1.35%
|
[11] |
1.35%
|
[7] |
1.35%
|
[11] |
|
|
|
Interest Rate and Floor |
[11] |
|
|
4.50%
|
|
|
|
4.50%
|
|
|
|
|
Principal Amount |
|
$ 13,176,000
|
[9],[31] |
$ 13,041,000
|
[20],[32] |
|
|
|
|
|
|
|
Investment cost |
|
13,373,000
|
[1],[9],[31] |
13,005,000
|
[2],[20],[32] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 14,039,000
|
[9],[31] |
13,092,000
|
[20],[32] |
|
|
|
|
|
|
|
Software | Senior Secured Tranche B [Member] | Exit Fee | Pollen, Inc. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
|
|
4.50%
|
|
|
|
|
|
|
Software | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 647,576,000
|
[1] |
526,253,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
648,620,000
|
|
529,402,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
15,683,000
|
|
39,387,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
11,508,000
|
[1] |
12,412,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
8,406,000
|
|
11,228,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
792,000
|
[1] |
950,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
373,000
|
|
1,034,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
120,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Jun. 20, 2013
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
471,327
|
|
|
|
471,327
|
|
|
|
|
Sustainable And Renewable Technology | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 19,659,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
6,904,000
|
|
19,625,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
7,109,000
|
[1] |
7,500,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
7,500,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Equity | Series E One Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,000,000
|
[1] |
2,000,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,438,000
|
|
$ 3,430,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 10, 2019
|
[5] |
May 10, 2019
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
188,611
|
|
188,611
|
|
188,611
|
|
188,611
|
|
|
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[11] |
|
|
9.00%
|
|
|
|
9.00%
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[11] |
|
|
3.95%
|
|
|
|
3.95%
|
|
|
|
|
Investment, Interest Rate, Floor |
[11] |
|
|
8.95%
|
|
|
|
8.95%
|
|
|
|
|
Interest Rate and Floor |
[11] |
|
|
9.00%
|
|
|
|
9.00%
|
|
|
|
|
Sustainable And Renewable Technology | Ampion, PBC. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 53,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 42,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 15, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
18,472
|
|
|
|
18,472
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Class A Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[35] |
|
|
$ 4,767,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[35] |
|
|
$ 591,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6],[35] |
|
|
Dec. 10, 2020
|
|
|
|
|
|
|
|
|
Shares | shares |
[35] |
|
|
3,000,000
|
|
|
|
3,000,000
|
|
|
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[5],[22] |
$ 3,153,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[5],[22] |
$ 243,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Dec. 10, 2020
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
[5],[22] |
304,486
|
|
|
|
304,486
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
[11],[26],[35] |
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[11],[35],[37] |
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Sustainable And Renewable Technology | Modumetal, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500,000
|
[1] |
$ 500,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 01, 2015
|
[5] |
Jun. 01, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,035
|
|
1,035
|
|
1,035
|
|
1,035
|
|
|
|
|
Sustainable And Renewable Technology | NantEnergy, LLC | Equity | Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 102,000
|
[1] |
$ 102,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Aug. 31, 2013
|
[5] |
Aug. 31, 2013
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
59,665
|
|
59,665
|
|
59,665
|
|
59,665
|
|
|
|
|
Sustainable And Renewable Technology | Pivot Bio, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,500,000
|
[1] |
$ 4,500,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,571,000
|
|
$ 3,164,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Jun. 28, 2021
|
[5] |
Jun. 28, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
593,080
|
|
593,080
|
|
593,080
|
|
593,080
|
|
|
|
|
Sustainable And Renewable Technology | Proterra, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 542,000
|
[1],[5] |
$ 543,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,280,000
|
[5] |
$ 4,043,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
May 28, 2015
|
[5] |
May 28, 2015
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
457,841
|
[5] |
457,841
|
[6] |
457,841
|
[5] |
457,841
|
[6] |
|
|
|
Sustainable And Renewable Technology | Halio Inc |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 111,000
|
|
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 218,000
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
456,883
|
|
|
|
456,883
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 155,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 83,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 22, 2014
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
325,000
|
|
|
|
325,000
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 63,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 28,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Apr. 07, 2015
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
131,883
|
|
|
|
131,883
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Agrivida Inc | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 120,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 20, 2013
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
471,327
|
|
|
|
471,327
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Equity | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 711,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 874,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Sep. 13, 2012
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
187,265
|
|
|
|
187,265
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 64,000
|
[1] |
$ 274,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 220,000
|
|
$ 699,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Apr. 30, 2013
|
[5] |
Sep. 13, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
93,632
|
|
280,897
|
|
93,632
|
|
280,897
|
|
|
|
|
Sustainable And Renewable Technology | Polyera Corporation | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 337,000
|
[1] |
$ 338,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 11, 2012
|
[5] |
Dec. 11, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
311,612
|
|
311,609
|
|
311,612
|
|
311,609
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 218,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 335,000
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
456,883
|
|
|
|
456,883
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 155,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 249,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 22, 2014
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
325,000
|
|
|
|
325,000
|
|
|
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
|
|
$ 63,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 86,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[6] |
|
|
Apr. 07, 2015
|
|
|
|
|
|
|
|
|
Shares | shares |
|
|
|
131,883
|
|
|
|
131,883
|
|
|
|
|
Sustainable And Renewable Technology | Senior Secured | Impossible Foods, Inc. | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-07
|
|
|
|
2022-07
|
|
|
|
|
Principal Amount |
[33] |
|
|
$ 15,022,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
|
|
19,379,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[33] |
|
|
$ 19,378,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Senior Secured | Ampion, PBC. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-05
|
|
|
|
2025-05
|
|
|
|
|
|
|
Investment, Basis Spread, Variable Rate |
[7] |
4.70%
|
|
|
|
4.70%
|
|
|
|
|
|
|
Investment, Interest Rate, Floor |
[7] |
7.95%
|
|
|
|
7.95%
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
1.45%
|
|
|
|
1.45%
|
|
|
|
|
|
|
Principal Amount |
[9],[17] |
$ 4,022,000
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[9],[17] |
3,953,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[17] |
$ 3,943,000
|
|
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Senior Secured | Pineapple Energy LLC | Debt Investments Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2022-01
|
|
|
|
2022-01
|
|
|
|
|
Principal Amount |
[15],[26],[35] |
|
|
$ 280,000
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[15],[26],[35] |
|
|
280,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[15],[26],[35] |
|
|
$ 247,000
|
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Senior Secured | Pineapple Energy LLC | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2023-12
|
|
2024-12
|
|
2023-12
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
[7] |
10.00%
|
|
|
|
10.00%
|
|
|
|
|
|
|
Principal Amount |
|
$ 3,156,000
|
[9] |
$ 7,500,000
|
[15],[20],[35],[37] |
|
|
|
|
|
|
|
Investment cost |
|
3,156,000
|
[1],[9] |
7,500,000
|
[2],[15],[20],[35],[37] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,961,000
|
[9] |
7,500,000
|
[15],[20],[35],[37] |
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Senior Secured | Exit Fee | Ampion, PBC. | Debt Investments 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Interest Rate |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
|
|
3.95%
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 7,109,000
|
[1] |
27,159,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
6,904,000
|
|
27,125,000
|
|
|
|
|
|
|
|
|
Media/Content/Info | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
348,000
|
[1] |
348,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
0
|
|
0
|
|
|
|
|
|
|
|
|
Media/Content/Info | Zoom Media Group, Inc. | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
348,000
|
[1] |
348,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Dec. 21, 2012
|
[5] |
Dec. 21, 2012
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
1,204
|
|
1,204
|
|
1,204
|
|
1,204
|
|
|
|
|
Electronics & Computer Hardware |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 2,498,000
|
|
$ 1,040,000
|
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
1,500,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,034,000
|
|
|
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Warrant Investment |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
692,000
|
[1] |
658,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
1,464,000
|
|
1,040,000
|
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
34,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 27,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Jun. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
8,511
|
|
|
|
8,511
|
|
|
|
|
|
|
Electronics & Computer Hardware | Skydio, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,034,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
[5] |
Mar. 08, 2022
|
|
|
|
|
|
|
|
|
|
|
Shares | shares |
|
248,900
|
|
|
|
248,900
|
|
|
|
|
|
|
Electronics & Computer Hardware | Skydio, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 557,000
|
[1] |
557,000
|
[2] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,153,000
|
|
$ 422,000
|
|
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Nov. 08, 2021
|
[5] |
Nov. 08, 2021
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
622,255
|
|
124,451
|
|
622,255
|
|
124,451
|
|
|
|
|
Electronics & Computer Hardware | 908 Devices, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 101,000
|
[1],[5] |
$ 101,000
|
[2],[6] |
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 284,000
|
[5] |
$ 618,000
|
[6] |
|
|
|
|
|
|
|
Investment, Acquisition Date |
|
Mar. 15, 2017
|
[5] |
Mar. 15, 2017
|
[6] |
|
|
|
|
|
|
|
Shares | shares |
|
49,078
|
[5] |
49,078
|
[6] |
49,078
|
[5] |
49,078
|
[6] |
|
|
|
Investment, Affiliated Issuer, Controlled [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 87,249,000
|
|
$ 84,039,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
80,325,000
|
[40] |
$ 73,504,000
|
[41] |
|
|
|
|
$ 65,835,000
|
|
$ 57,400,000
|
Investment, Affiliated Issuer, Controlled [Member] | Gibraltar Business Capital, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[42] |
37,662,000
|
|
|
|
|
|
|
|
40,737,000
|
|
|
Investment, Affiliated Issuer, Controlled [Member] | Hercules Adviser LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[42] |
33,945,000
|
|
|
|
|
|
|
|
16,804,000
|
|
|
Investment, Affiliated Issuer, Controlled [Member] | Tectura Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[42] |
8,318,000
|
|
|
|
|
|
|
|
8,294,000
|
|
|
Investment, Affiliated Issuer, Controlled [Member] | Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[42] |
400,000
|
|
|
|
|
|
|
|
|
|
|
Investment, Affiliated Issuer, Controlled [Member] | Sustainable And Renewable Technology | Senior Secured Tranche A [Member] | Pineapple Energy LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Kind |
|
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Investment, Affiliated Issuer, Controlled [Member] | Sustainable And Renewable Technology | Senior Secured Tranche B [Member] | Pineapple Energy LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment, Interest Rate, Paid in Cash |
|
|
|
10.00%
|
|
|
|
10.00%
|
|
|
|
|
Principal Amount |
|
|
|
$ 280,000
|
|
|
|
|
|
|
|
|
Investment, Affiliated Issuer, Noncontrolled [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
0
|
|
13,547,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
0
|
|
9,458,000
|
[41] |
|
|
|
|
9,712,000
|
|
8,340,000
|
Investment, Affiliated Issuer, Noncontrolled [Member] | Pineapple Energy LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
|
|
12,547,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
0
|
[42],[43] |
8,338,000
|
[41] |
|
|
|
|
8,469,000
|
[42] |
|
Investment, Affiliated Issuer, Noncontrolled [Member] | Black Crow AI, Inc. affiliates |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[42] |
0
|
[43] |
|
|
|
|
|
|
1,243,000
|
|
|
Investment, Affiliated Issuer, Noncontrolled [Member] | Sustainable And Renewable Technology | Senior Secured Tranche A [Member] | Pineapple Energy LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
|
7,500,000
|
|
|
|
|
|
|
|
|
Investment cost |
|
|
|
7,500,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[41] |
|
|
7,500,000
|
|
|
|
|
|
|
|
|
Investment, Affiliated Issuer, Noncontrolled [Member] | Sustainable And Renewable Technology | Senior Secured Tranche B [Member] | Pineapple Energy LLC |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
|
|
280,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
[41] |
|
|
247,000
|
|
|
|
|
|
|
|
|
Investment, Affiliated Issuer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
87,249,000
|
|
97,586,000
|
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 80,325,000
|
[40] |
$ 82,962,000
|
[41] |
|
|
|
|
$ 75,547,000
|
|
$ 65,740,000
|
|
|